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Since the identification as 5-hydroxy-
tryptamine of both enteramine, a constituent of
enterochromaffin cells, and serotonin, the vaso¬
constrictor principle arising in blood when it clots,
much interest has been directed to its study.
Enteramine was described by Erspamer (1935)
and has been studied by him and his co-workers for
twenty years. They have shown its presence in
certain tissues of many animal species and in every
case these tissues are largely made up of entero-
chromaffin (argentaffin) cells. As a result of
diuresis measurements in rats, Erspamer believes
that enteramine is a hormone concerned with the
control of diuresis. In physiological doses
enteramine causes a marked reduction of urine flow.
Investigations over many years on vaso-
constrictor principles arising in blood were greatly
clarified by the work of Rapport, Green and Page,
CL94Sa and b), They isolated a vasoconstrictor from
serum/
2
serum which they called serotonin. It was shown
by Rapport (1949) to be 5-hydroxytryptamine
creatinine sulphate.
After synthetic 5-hydroxytryptamine salts
were prepared both enteramine and serotonin were
shown to be identical with one of these - their
pharmacological activities being due to the
properties of the base.
6-hydroxytryptamine was shown to be present
in the tissues of the dog brain.(Amin, Crawford and
Gaddum; 1946a and b). Its spasmogenic action on
the isolated oestrous uterus of the rat was blocked
by lysergic acid diethylamide which has very power¬
ful actions on the brain (Gaddum, 1963b} Stoll,
1947). Also 6-hydroxytryptamine seemed to act on
certain preparations through a stimulation of
ganglion cells.
For these reasons it seemed worth while that
a study of the distribution of 6-hydroxytryptamlne
throughout the various tissues of a certain species
should be undertaken in the hope that some clue of
its physiological function might become apparent.
The experiments described in Part II sought to




Because it seemed advisable to exclude the
effect of adrenaline from the estimations of tissue
extracts (page 59), these methods were tried in turn
to achieve this. In the first, a method of paper
chromatography was investigated, but a suitable
solvent system, causing adequate separation of
adrenaline from 5-hydroxytryptamine, was not found
among those tested. Second, a method of assay in
which the adrenaline effect was specifically
antagonised was considered. Here, the isolated
perfused ear of the rabbit was used, but the prepar¬
ation was very tedious and the discrimination tended
to be poor. Finally, a method was developed In
which an enzyme preparation of mushrooms was incubated
with the extracts and this caused a destruction of
the adrenaline effect. Assays of the mushroom
treated samples were made on the isolated oestrous
uterus of the rat.
The 5-hydroxytryptamine used in the experiments
and as the reference standard in all the biological
assays of tissue extracts was a synthetic preparation
of 5-hydroxytryptamine creatinine sulphate - a
white crystalline powder, kindly supplied to
Professor Gaddum by Messrs* Upjohn Inc. of/
4
of Kalamazoo, Michigan, U.S.A.
In the text, " SHT-equivalent11 means activity-






Since the beginning of this century, it
has been demonstrated by various workers that a
vaso-constrictor principle is released when blood
clots,
Brodie (1903) was working on the perfusion
of isolated organs. He stated that "serum is by
no means a completely inert fluid", By the use
of citrate to prevent clotting he found that his
preparations were much more satisfactory and he
concluded that some 'irritant* was produced by the
clotting process.
In similar perfusion systems Battelli (1905)
found that defibrinated blood failed to flow easily
through the vessels because of vasoconstriction.
A careful study by Janeway and Park (1912)
confirmed the conclusions of these and other workers
that a vasoconstrictor arose in blood during clottin
and that it was not adrenaline because it constricte
coronary, as well as carotid, rings and stimulated
intestinal smooth muscle. They stated that its






Stewart and Zucker (1913) showed that citrate
plasma had no effect on their sheep arterial ring
preparation, but that the platelets from citrate
blood possessed a high vasoconstrictor activity.
They suggested that the clotting process as such,
(i.e. fibrin to fibrinogen) was not directly con¬
cerned with the liberation of this vasotonin, to
which was ascribed a role in haemostasis,
A review on serum vasoconstrictor, supple¬
mented by many experiments, was published by Janeway,
Richardson and Park (1918). They confirmed that
plasma could be obtained quite free from vaso¬
constrictor activity, vis. in the absence of clotting
or trauma to the platelets. They showed that the
vasotonin arising from platelet rupture was not a
protein, nor was it adrenalinej it was more readily
extracted by water and by alcohol than by ether or
chloroform5 and it was dialysable and therefore
crystalloid. They stated that its appearance was
not dependent on the actual formation of the clot,
nor was it related to any of the factors concerned
in coagulation with the possible exception of
thromboplastin.
Both a temporary and a permanent vasotonin
were/
7
were described, in heparinised blood and in
defibrinated blood by Bayliss and Ogden (1933),
The first was "temporary" because it could be
destroyed by passage of the blood through a lung-
■
kidney preparation. The vasoconstrictor effects
were antagonised by ergotoxin Gaddum- Hebb.
Silver and Swan (1963) showed recently that the
vasoconstrictor and bronchoconstrictor action of
serum was removed by passage of the blood through
the lungs of a cat. Also, both the broncho-
constriction and vasoconstriction were antagonised
by ergot alkaloids.
It is interesting to note another observation
of an ergot alkaloid effect on serum vasoconstrictor
actions. Heyraans, Bouckaert and Moraes (1932)
showed a reversal of the constriction of rabbit ear
vessels caused by defibrinated blood, by previous
injection of ergotamine. Landis, Wood and Guerrant
(1943) emphasized the necessity to exclude the
presence of serum vasotonin (i,e, the occurrence
of coagulation) during studies on pressor sub-
I
stances of renal or other origin in the blood.
Further work on platelets was done by
Zucker (1944). She confirmed that the origin
of/
8
of serum vasoconstrictor was the platelets and that
this vasotonin also stimulated strips of rat
intestinal muscle. Studies of a pharmacologically
active preparation from human huffy coat showed that
this stimulated intestine, uterus, nictitating
membrane and carotid artery rings. It constricted
vessels of the cat's tail but not those of the
rabbit's ear. She demonstrated that the prepar¬
ation was heat-stable and dialysable, and that it
was not histamine, tyramine, a choline-ester nor a
sympathomimetic. Most of its actions seem now to
be those of 5-hydroxytryptamine with the notable
exception of its lack of action on the rabbit ear
vessels. This may have been due to the differences
in technique of perfusion of the ear vessels, or to
a loss in activity during the rather drastic purifi¬
cation of the preparation.
Her later studies showed that the presence
of both calcium and plasma were necessary for the





A study of the vasoconstrictor activity
of blood serum by Rapport, Green and Page (1947;
1948a and b) led to the isolation of a substance
which they called serotonin. This substance caused
constriction of isolated perfused blood vessels and
contraction of intestinal muscle strips. During
the purification of serotonin, the perfused ear of
the rabbit was used to yield approximately quanti¬
tative results, in activity estimations of the
various products.
The serum was adjusted to pH 4.5, extracted
with various organic solvents and the active
principle in the product was crystallised as the
5-nitrobarbituric (dillturic) acid salt. Study of
this salt showed serotonin probably to be 5-hydroxy
tryptamlne creatinine sulphate (Rapport, 1949). This
material was synthesised by Hamlin and Fisher (1951)
and was shortly shown to be the same as the natural
serotonin (Page, 1952), Oxidation experiments on
serum and on purified serotonin had given evidence
favouring the conclusion that serotonin is solely
responsible for the vasoconstrictor action of




Thrombocytin is a vasoconstrictor
principle found in serum only when platelets are
present in the plasma at the time of clotting.
Using the method of Kapport et al (1949a) for
purification of the serum activity as the nltro-
barbiturate complex, Held and Rand studied the
pharmacological properties of serotonin. They
determined its actions on various test organs and
intact animals and they found that these were all
shared by serum itself. They discovered that the
complex prepared from the serum from "platelet free'1
plasma was almost devoid of activity, whereas that
prepared from serum of "platelet rich" plasma had a
high activity (Reid and Rand, 1951), Thrombocytin
was thus shown to be identical with serotonin - a
series of comparisons on four different test organs
was made (Rand and Reid, 1951).
When the synthetic compound, 5-hydroxy-
tryptamine creatinine sulphate,was available, Reid
(1952) made a careful study cf its circulatory
effects| while Reid and Rand (1952) detailed its
pharmacological actions and showed these to conform





In 1933, Vialli and Erspamer described
the enterochromaffin argentaffin cells, which occur
in the mucosa of the gut of vertebrates. They dis¬
tinguished these cells from acidophil basal-granu¬
lar cells, by the ability of the former to stain
with diazotised p-nitraniline and to give positive
chromaffin and argentaffin reactions (Vialli and
Erspamer* 1933). The mucosa of the fundus region
of the rabbit's stomach was found to be very rich
in these cells (Erspamer, 1936). The component of
the enterochromaffin cells which Erspamer found to
be responsible for their staining reactions he
called "enteramine". He began to investigate more
fully its chemical and pharmacological properties
in acetone and alcohol extx^acts of tissues rich in
these cells, Enteramine seemed to be a di- or
poly- phenolic amine (Erspamer, 1940), Soon Vialli
and Erspamer (1942) recognised the presence of a
second substance in the extracts. This gave the
same colour reactions as enteramine but was not
pharmacologically active. They found that it could
be made so, by heating it in solution at pH 7 - at
100°C for 10 minutes. They called it Enteramine I
(or inactive enteramine),(also, Erspamer, 1942b),
Extracts/
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Extracts containing enteraraine stimulated
the atropinised oestrous uterus of the rat and the
mousej stimulated the isolated atropinised duo¬
denum of the rat, and the urinary bladder of the
dog, both in vitro and in vivoj and had a hypo¬
tensive action in the rabbit (Erspamer, 1940).
The presence of entermine in the human
spleen was demonstrated by Ersparaer (1943) in a
study of acetone extracts of normal and pathological
organs. A series of papers followed in which
details are given of the finding of enteramine, or
an enteramine-like substance, in extracts of varioui
organs of vertebrates and invertebrates. Viz, -
extracts of gastro-intestinal tract
and spleen of fishes (except Teleostei
and Cyelostoraa);
extracts of gastrointestinal tract of
Aseidiai
extracts of posterior salivary glands of
Octopus vulgaris and Eledonej
extracts of hypobranchial body of Murex;
extracts of amphibian skin.
In 1946, the indolalkylamines in the venom
of the toad, known as Bufotenine and Bufotine were
shown by Erspamer to have chemical and pharmacologi¬
cal properties, very similar to those of enteramine




was probably an indolalkylaiuine and not a poly-
phenolic amine. Later he suggested that it was a
derivative of indole having a phenolic-OH as well
as a side chain with a primary or secondary amino
grouping ( Erspaxaer, 1948a).
Erspamer and Ottolenghi (I960) showed such
a parallel distribution of enteramine (and: the
enteraiaine-llke substances) and an anti-diuretic
principle in acetone extracts of tissues, that it
seemed almost certain that enteramine itself
possessed this anti-diuretic property. Pot only
was the distribution similar but with care the
anti-diuretic property of an extract could be
shown to be roughly proportional ic the enteramine
activity as measured colorimetrically and pharma¬
cologically, Then, any treatment destroying the
enteraiaine activity also destroyed the anti¬
diuretic activity. Thus it was found that entera¬
mine inhibits normal and water diuresis, as well as
that due to xanthines, mercurials, salts and urea.
At about the same time, Erspamer and
Ghiretti (1951) found that enteramine-containing
extracts had a positive inotropic, chronotropic and
tonotropic action oa the molluscan heart, particu¬
larly on the heart of Helix pomata.
The/
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The chemical and physical characterization
of enteramine became clearer, and, particularly
with the aid of paper chromatography, Erspamer and
Boretti (1951) were able to confirm the presence
of enteramine in all tissues in extracts of which
enteramine-like substances had been demonstrated
biologically and chemically. Enteramine seemed a
single entity no matter what species or organ was
its source.
Meanwhile, the pharmacological studies of
enteramine effects on diuresis were continued by
Erspaiaer and Ottolenghi (1950, 1951 and 1952), so
that Srsparser was soon able to conclude that
enteramine in the animal body is the specific
hormone of enterochroraaffin cells. Also, it is
concerned, in certain mammals with anti-diuresis by
the control of intraglomerular pressures, i.e. by
constriction of the afferent vascular bed of the
glomerulus.
Then enteramine was isolated as the pure
picrate from extracts of the posterior salivary
glands of Octopus vulgaris and also from extracts
of the skin of Biscoglossus pictus. These were
tryptamine which was synthesised at about the same
time/
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time (Brspamer and Asero, 1951 and 1952} and Asero,
Colo, Brspamer and Vercellone, 1952).
The 'stable antidiuretic substance* (Stable
ADS) described at this time in serum by Ginsburg
and Heller (1951 and 1953) was later identified by
Erspamer and Sala (1954) as 6-hydroxytryptamlne.
In experiments on dogs, Earac (1953) was
unable to find any reduction in blood flow through
the kidney, after the administration of 5-hydroxy-
tryptamine. He concluded that the antidiuresis
here was not attributable to renal vasoconstriction
and was therefore caused by some other mechanism
than that demonstrated by Brspamer and uttolenghi
(1952) in the rat.
Other studies of 5-hydroxvtryp tamine distri¬
bution.
After synthetic 5~hydroxytryptamine became
available for comparison, its distribution in
tissues was studied by a number of workers.
Erspamer and Faustini (1953) found that
5-hydroxytryptamine occurred in the serum and
haemolyraph as well as the spleens of many species.
Erspamer could now make more accurate estimates of
5-hydroxytryptamine venteramine) activity and he
studied/
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studied the concentration of 5-hydroxytryptamine
in the serum of patients suffering from various
diseases (Erspamer 1964a and b).
Udenfriend, Clark and Titus (1962) were
aware of the high concentrations of N-methyl-
indolalkylamines in toad venom (Bufo marlnns), so
they suspected the presence of 6-hydroxytryptamine
there also. Isotopic and chromatographic techni¬
ques made it possible for them to demonstrate 6-
hydroxytryptaraine to the extent of about 0.1% of th
dry weight of the venom. This discovery made it
possible for them to use B. aarinus in their
further studies of 6-hydroxytryptamine metabolism
( see pf34)•
Acetone extracts of the wall of the
digestive tract of dogs and rabbits were estimated
for 6-hydroxytryptamine activity by Feldberg and
Toh (1963) on the atropinised rat colon. They
found much more activity in the mucosa than in the
muscularis externa. In the dog, the pyloric
mucosa contained most 6-hydroxytryptamine whereas
in the rabbit, the stomach fundus mucosa contained
more than the pyloric mucosa. The extracts were
then assayed for substance P (cf. von Suler and
Gaddum/
16a
Gaddum, 1931), on guinea pig ileum. This
preparation was first treated with atropine and
v ; "
mepyramine and then desensitised to 5-hydroxy-
tryptamine by a large dose of tryptamine (Gaddusi,
1953), (This tryptamine treatment sensitised the
tissue to substance P.)
Amin, Crawford and Gsddum (1952 and 1354)
have developed a method for the separate extraction
of 5-hydroxytryptamine and substance P from tissues.
By treating the samples of tissue with 20 volumes of
acetone they obtained quantitative extraction of
the 5-hydroxy'tryptamine in the acetone and left
the substance r in the insoluble residue. If the
latter was treated with acid, (N hydrochloric acid),
the substance P passed into solution.
By the application of this method, they
obtained estimates of 5-hylroxytryptamine distri¬
bution in the central nervous system of dogs.
Assays were made on the atropinised oestrous uterus
of the rat. In all cases, a specificity test of
the extract activity was made with L. 3.1). This
compound was found by Gaddum (1353) to be a
specific antagonist of 6-hydroxytryptamine con-
tractions of rat oestrous uterus. The results of
this/
16b
this test together with chromatography and parallel
assay on the perfused ear of the rabbit showed that
the active principle of the acetone extracts was
6-hydroxytryptamine,
The areas containing most 6-hydroxy-
tryptamine were the hypothalamus, area postrema,
mid brain, co'lliculi and nuclei cuneatus and
gracilis. There appeared to be no correlation
between the amount of substance P and the amount of
6-hydroxytryptamine in the nervous tissues studied,
(Amin, Crawford and Gaddura, 1954).
'
In studies of the vasoconstrictor action
of rabbit plasma, Holgate (1963) showed a high
histamine equivalent in the plasma of heparinised
blood. Assays were made on the perfused ear of the
rabbit. Though responses to standard histamine were
abolished by mepyramine, the extract responses were
little affected, so he re-estimated the activity in
terms of standard 6-hydroxytryptamine. This gave
the value G.6pg/ral plasma. Plasma from citrated
I .'
blood gave a much lower histamine equivalent and
this activity was almost completely abolished by
mepyramine.
Humphrey and Jaques (1953 and 1964.) studied
the release of histamine and 6-hydroxytryptamine
from/
1?
from platelets by antigen-antibody reactions. This
work was done *in vitro* with carefully collected
and washed *buffy layer* of rabbit blood, partially
purified antibody and plasma. The 5-hydroxy-
tryptamine was assayed on rat colon or rat oestrous
uterus and a specificity test was made by the
6-hydroxytryptaiaine specific antagonist,2-methyl,
3-ethyl, 5-amino indole. Citrated plasma did not
have this 'releasing* activity.
5-hydroxytryptamine and histamine were
liberated in parallel, though the actual quantity
of 5-hydroxytryptamine was about 3 times that of
histamine.
With a fluorimetric method of estimation
Udenfriend and Weissbaeh (1954) have been able to
confirm that the platelets contain all the
5-hydroxytryptamine which can be shown to be
present in whole blood. The plasma contains none.
Estimates of 5-hydroxytryptaraine-equivalent were
v
quoted for a few animals. Other studies,with Ci4
labelled tryptophan showed the haIf-life of platelet
5-hydroxytryptamine to be 8-5 days, which is in
close agreement with the reported half-life of the




Intestinal tract showed a more rapid turnover.
They found no evidence for a concentrating
mechanism for 5-hydroxytryptamine within the plate¬
lets nor for its formation "by the platelets from
5-hydroxytryptophan. They therefore suggested that
5-hydroxytryptamine is synthesised and incorporated
at the site of platelet formation and that it is
metabolieally inert until the platelet disintegrates
(Udenfrienu and Weissbach, 1954).
But Humphrey and Toh (1954) contended that
since *in vitro* dog platelets were able to adsorb
5~hydroxytrypt&mine from their surrounding fluid,
the platelets were likely to have such a power
within the animal body. They suggested that this
property prevents the 5-hydroxtryptamine concen¬
tration in plasma from rising above a very low
threshold.
The heart of Venus mercenaria was used by
Twarog and Page (1953) in. conjunction with paper
chromatography for investigations of the 5-hydroxy-
tryptamine content of various tissues of dogs,
brains of rats and rabbits,as well as blood and
serum. This molluscan heart is very sensitive
to/
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to stimulation by 6-hydroxytryptamine-in concen-
0
trations as low as 10" - and to inhibition by
acetylcholine (p. 57). The latter effect can be
blocked by myiolon, The authors found 6-hydroxy-
tryptamine activity in all the samples of brain
tissue, but not in the nerve and muscle samples.
Variable responses to kidney and left ventricle
samples were recorded. Saline dilutions of blood
and acetone extracts of serum (both from normal
dogs), yielded similar concentrations of 5-hyuroxy-
tryptamine/ml serums also, the activity in dog
urine showed an excretion of 0.06-4 pg/ml which
was increased after intravenous infusion of
5-hydroxytryptamiii.e solution,
Florey and Florey (1953) studied aqueous
extracts of the nerves and ganglia of crayfish
and cuttlefish for their excitor action on the
hearts of the same species. They showed that the
activity of the extracts, relative to 5-hydroxy~
tryptamine was equal on two test organs and that
various chemical and physical tests gave similar
results. Thus they state that the nervous tissue
of these crayfish contained 30-66 5-hydroxy-
tryptamine/g dry weight.
Bacq/
+Mytolon - 2 $5-Bis (3-diethylamino
propyl amino) benzoquinone-bis-benzyl chloride.
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Baeq., Fischer and Ghiretti (1952) showed
that on nerve stimulation the perfused salivary
glands of 0. Vulgaris secrete 5~hydroxytryptamine
in their saliva $ also 5-hydroxyt ryp tamine itself
has a secretory effect on these glands. The glands
of 0. maeropus did not respond in this way.
Histological studies by Barter and Everson
Pearse (1953) led them to conclude that they have
detected 5-hydroxytryptamine in the enterochronaffin
cells. They showed that the granules, typical of
these cells,were an artefact of the fixing process,
but were derived from 5~hydroxy tryptaiain©.
A carcinoid tumour is a local hypertrophy
of enterochromaffin cells It was because of this
that Lembeck was anxious to estimate the enteramine
(5-hydroxytryptamine) content of 3uch a tumour.
V.
After some considerable time he obtained a specimen
and was able by biological methods, with the aid of
paper chromatography, to estimate that the tumour
contained 2-5 mgm 5-hydroxytryptanine/g fresh
tumour. Thus he was able to agree with Erspamer
that the origin of 5-hydroxytryptamine in the animal




Recently the "carcinoid syndrome" has been
described, particularly in a series of seven
carcinoid cases detailed by Thorson, Bibrck,
Bjbrkman and Waldenstrom (1954). The syndrome
consists of carcinoid of the ileura, valvular
disease of the righx side of the heart, flushing
of the skin with an unusual type of patchily
distributed changing cyanosis and »asthmaticf
attacks. These authors believed the cause to be
a malignant carcinoid having hormonal properties.
They noted that 5-hydroxytryptaiaine seemed the
most likely of the vaso-active substances known to
have effects corresponding with the signs and
symptoms of the syndrome. The finding of a con¬
siderable concentration of 5-hydroxytryptamine in
a carcinoid, by Lembeck (1953 and 1954), supported
this view.
Patients suffering from carcinoids experi¬
ence sudden flushing attacks. During such attacks,
Pernow and Waldenstrom (1954) sampled blood from
two patients. They prepared acetone extracts of
the serum and found a high 5-hydroxytryptamine
equivalent in both cases:-
5.2 pg and 6.5 pg hydroxytryptamine/ml
serum compared with the figures of 0.03-0,20 pg/ml
given/
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given by Erspamer and Faustini (1963) for normal
humans.
A case of carcinoid was diagnosed after
operational removal of a malignant tumour which
was causing obstruction of the ileum. Ten days
from the operation, a blood sample was taken. The
serum was extracted and estimated by the method
described in detail on p. 50. This sample had a
5-hydroxytryptamine eqivalent of 2.8-3.2 |xg/ml
serum, which is about ten times greater than the
equivalent of serum from normal persons estimated
in the same manner. A full description of this
case and the details of the investigations made
are given by Duncan, Garven and Gibbons,(1955).
Pharmacological properties of 5-hydroxy-
trvntamine.
Shortly after the synthesis of
5-hydroxytryptamine creatinine sulphate, surveys
of its pharmacological properties were made in
Australia by Reid and Rand (1962) and by Reid (1932)
and in America by Freyburger, Graham, Rapport, Seay,
Govier and Yander Brook (1962).
Their findings can be summarised as follows:
a)/
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a) Intravenous injection of 5-hydroxy-
tryptamine into chloralose cats caused -
an initial fall of systemic arterial
pressure associated with increased resist¬
ance in the pulmonary circulations
followed by a rise, due to vaso¬
constriction, (demonstrable in hind-limb,
intestines and kidney):
and then by a more prolonged fall,
Apnoea and brief bronchoconstriction
occurred also.
b) Dogs presented a varied response to
intravenous injection of 5-hydroxytryptamine -
sometimes pressor,sometimes depressor. Pithing of
the dogs caused a more regularly pressor response.
c) The nictitating membrane of the cat was
constricted, as was the pupil, in response to
intracarotid injection of 5-hydroxytryptamine.
d) Injection of 5-hydroxytryptamine into
the superior mesenteric artery of the eviserate cat
caused the liberation of adrenaline.
e) The 'in situ* uterus of the non-gravid
adrenalectomised cat relaxed on intravenous
injection,/
24
injection of 5-hydroxytryptamine. •
f) The uterus of the rat was stimulated by
5-hydroxytryptamine.
g) The bladder of the dog was stimulated bj
5-hydroxytryptamine.
h) The jejunum of the guinea-pig was
stimulated by 5-hydroxytryptamine.
i) A spiral strip of the sheep's carotid
artery was contracted by 5-hydroxytryptamine.
j) Intradermal or subcutaneous injection
of 5-hydroxytryptamine in the human skin caused a
slight red reaction without itching or wealing
and a local vasoconstriction.
Toxicity - Intravenous injection.
In mice - L.D.50 = 160 mgrn 5-hydroxytryptanine/kg
In rats - L.D.50 = 30 mgm 5-hydroxytryptamine/kg
Since the above results were reported,
observations on the pharmacology of 5-hydroxytrypta-
mlne have been made by many other workers.
»
•




effects of 5~hydroxytryptamine in the isolated
perfused lungs of the cat. 5-hydroxytryptamine
caused a distinct bronchoconstriction and a
constriction of the pulmonary blood vessels. Both
these effects were antagonised by lysergic acid
diethylamide and by dihydroergotaralne.
In the cat, Schneider and Yonkman (1953)
recorded an increase in frequency of vagal impulses
from the stretch receptors in the lung, after
injection of 5-hydroxytryptamine. Respiration
ceased after an expiration but later tachypnoea
developed, probably because of central stimulation,
for the vagal activity was still increased.
Comroe, van Lingen, Stroud and Roncoroni
(1853) showed well defined apnoea in chloralose
cats with very small doses of 5-hydroxytryptamine,
(10 pg/kg), and suggested that a stimulation of
chemo-receptors occurred. Pulmonary vasoconstrict¬
ion was recorded also.
"5-hydroxytryptamine is by no means a pure
hypertensive substance, in as much as it may possess,
according to circumstances, hypertensive, hypo¬
tensive and biphasic pressure actions". This
statement was made by Erspamer (1952c) and supported
the/
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the conclusions of other workers (Page, 1952}
Freyburger et al. 1952} Page and McCubbin, 1953a).
Although 5-hydroxytryptamine had no effect on
'in vitro' blood-clotting systems, it caused
immediate haemostasis when given intravenously
to animals with peripheral wounds,(Correll, Lyth,
Long and Vanderpoel, 1952). A similar response
occurred in heparinised rats, and though the effect
of an intravenous dose is of limited duration this
can be extended by further injections. Correale
(1954) recorded the results of similar experiments.
He found that subcutaneous injections of 5-hydroxy¬
tryptamine reduced the bleeding time of the cut tail
veins of the rat. Page (1952) also suggested that
5-hydroxytryptamine had a haemostatic property due
to local vasoconstriction.
The responses of the heart of Venus mercen-
aria to 5-hydroxytryptamine were first described by
Welsh (1953), He had previously reported that this
heart was very sensitive to inhibition by acetyl¬
choline and that it was relatively much less sensit¬
ive to stimulation by adrenaline, noradrenaline,
tyramine and histamine (Welsh and Taub, 1948).
5-hydroxytryptamine, however, excited the heart at
concentrations as low as 0.0002 pg/ml. He found
that/
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that electrical stimulation of the visceral ganglion,
after block of cholinergic inhibition, caused a
stimulation very similar to that elicited by
5-hydroxytryptamine. Ergot and lysergic acid
diethylamide, which blocked 5-hydroxytryptamine
excitation, also abolished the effect of direct
electrical stimulation (Welsh, 1954). Since
5-hydroxytryptamine was found to be present in the
ganglia of Venus mercenaria, Welsh concluded that
it was the normal mediator of excitatory nerves in
this mollusc.
♦ • •
The stimulating effect of 5-hydroxytryptamine
(enteramine, serotonin) on the Helix heart, and on
the vessels of the perfused ear of the rabbit have
already been mentioned (see p.11 and p.5 respect¬
ively) .
On the exposed base of a blister caused by
cantharidin, 5-hydroxytryptamine and tryptamine
both caused pain which was indistinguishable from
that produced by serum. Plasma produced no pain.
There was a specific refractory period after the
pain stimulation, which in the case of 5-hydroxy¬
tryptamine and serum was a reciprocal block, but was




Antagonism of responses to 5-hydroxy~
trvptamine.
For some time it has been clear that a drug
having a specific antagonistic action to responses
caused by 5-hydroxy tryptamine would be most useful
Such a drug might help us to understand the physio¬
logical function of 5-hydroxytryptaaiine; it might
help in the identification of 6-hydroxytryptamine in
tissue extracts*, it might be useful also in therapy.
1) Ergot alkaloids and lysergic acid
diethylamide.
Fingl and Gaddurn (1953) made a study
of the activity of ergot alkaloids, with the above
ideas in mind. They found that dihydroergotamine
gave a highly specific irreversible blockade of
5-hydroxytryptamine and tryptaiaine responses in
the isolated rat uterus. It also blocked both
adrenaline and 5-hydroxytryptaaine constrictions of
rabbit ear vessels, but was more effective against
the 5-hydroxytryptamine response. Ergotamine gave
similar results (also Gaddum and Eameed, 1954).
Gaddum (1953b) found that lysergic acid
diethylamide (L,S.D.) had also a highly specific
antagonistic power, with reference to 5-hydroxy-
tryptaiaine/
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tryptamine responses on "both the rat uterus and the
rabhit ear vessels. (Lysergic acid diethylamide
is related structurally to the ergot alkaloids 5
it has powerful effects on the human brain even in
doses of 1 pg/kg).
The ergot alkaloids were studied too by
Erspamer (1953). He showed that dihydroergotaiaine
and hydergin, blocked the antidiuretic response
of rats to subcutaneous infection of 5-hydroxytryp-
tamine. (Hydergin is a mixture of hydrogenated
alkaloids of ergot).
Ergotoxine was reported by Woolley and Shaw
..
(1953) to have a reversible but incomplete antagon¬
istic effect on 5-hydroxytryptamine stimulation of
isolated carotid rings.
On isolated guinea-pig ileum the antagonism
between ergot alkaloids and 5-hydroxytryptaraine is
feeble and less clearly specific (Gaddura and Hameed,
1954).
2) Adrenolytic drugs..
Various other adrenolytic drugs have
been tested for antagonistic effects on 5-hydroxy¬
tryptamine responses in various tissues.
Dibenamine was found, by Erspamer (1952b) to
be a powerful inhibitor of the spasm induced by
5-hydroxytryptamine/
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5-hydroxytryptamine on the isolated rat uterus}
this action was quite specific and was suggested
to be a case of substrate competition.
In the isolated ear of the rabbit,
adrenaline responses were more readily blocked by
dibenamine than those of 5-hydroxytryptamine, but
the latter were also affected (Fingl and Gaddum,
1953} Gaddum and H&rneed, 1954). On the Isolated
guinea-pig ileum, 5-hydroxytryptamine and histamine
responses were reduced about equally with recovery
only of the 6-hydroxytryptamine effect, after the
dibenamine was washed out (Gaddum and Hameed, 1954).
Piperoxane (10~ ) abolished the power of
adrenaline to cause vasoconstriction in the per¬
fused rabbit ear without causing any change in the
response to 5-hydroxytryptamine (Fingl and Gaddum,
1953} Gaddum, 1954} Gaddum and Hameed, 1954).
6
Regitine in the same concentration (10" )
also has a very marked anti-adrenaline effect.
Page and McCubbin (1953b) noted that piperoxane gave
a transient reversal of the 5-hydroxytryptamine
pressor response in normal dogs.
In studies of adrenergic blocking drugs,
Leitch, Leibig and Haley (1954) measured effects on
the response of the rat seminal vesicle to
adrenaline./
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adrenaline, Dibenzyline had the highest blocking
potency with also a very high degree of fixation to
the tissue, Dibozane was next in blocking potency
to dibenzyline (being about 10k as active as
piperoxane), but unlike the latter, dibozane was
easily washed out of the tissue and a recovery of
the adrenaline response was recorded. These
compounds have been studied here for anti-adrenaline
and anti-5-hydroxytryptamine effects on the isolated
perfused ear of the rabbit. The results are
reported on p, 88.
Ephedrine effects on the responses to
adrenaline of the perfused ear of the rabbit were
described by Gaddura and Kwiatkowski (1938). They
showed that low concentrations (10"" ) potentiated
adrenaline vasoconstrictions, whereas higher con¬
centrations antagonised them. The potentiation
effect was ascribed to an inhibition by the
ephedrine of tissue amine-oxidase, and the
antagonistic effect to a blocking of the adrenaline
receptors,
6-hydroxytryptamine is axso destroyed by
amine-oxidase (Biaschko,1962j Freyburger et al.
1862). So Gaddum and Hameed (1964) tested the




in the rabbit ear. In these experiments, 10"
ephedrine was found to be already inhibiting
adrenaline but greatly increasing the response to
6-hydroxytryptamine. This was explained as the
blockade of adrenaline receptors, the persistence
of inhibition of amine-oxidase and the absence of
any block of tryptamine receptors.
3) Local anaesthetics.
Cocaine as well as being a
.
local anaesthetic, is an inhibitor of amine-oxidase
C Fhilpot, 1940),
The constrictor effect of 5-hydroxytryptamine
on sheep carotid artery strips was increased by
cocaine, (Reid and Rand, 1952) but the authors gave
'
no indication of the specificity of this effect. On
the isolated rat uterus, cocaine (10"*") was shown
to potentiate the responses to both 5-hydroxy-
tryptamine and acetylcholine. Higher concentrations
gave a temporary inhibition of the responses to both
drugs. Reid and Rand, therefore concluded that
, I
there was no support here for the inhibition of amine-
t &
oxidase theory. But in the rabbit ear, 10"
cocaine potentiated the adrenaline vasoconstriction




On the guinea-pig ileum, cocaine caused a
reversible inhibition of the spasm induced by
5-hydrcxytryptamine, without much effect on histamine
or acetylcholine responses (Sinha and West, 1953 J
Robertson, 1953J Rocha e Silva, Valle and Picarelli
1953 J Gaddurn and Hameed, 1954). This was explained
by the various workers on the theory that 5-hydroxy-
tryptamine acts through the nerves of the intestine
and cocaine prevents its action by paralysing these
nerves,
A number of other local anaesthetics,
including procaine and cinchocaine, were studied by
Sinha and West (1953) for their antagonism of
5-hydroxytryptamine responses. They found a fair
degree of agreement between the antagonistic
potencies of some, against 5-hydroxytryptamine stim¬
ulation of rabbit ileum and rabbit auricles and the
local anaesthetic properties of these drugs. Others
were shown to antagonise the action of 5-hydroxy¬




was found to be less effective in abolishing
5-hydroxytryptamine spasm of guinea-pig ileum than
in/
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in abolishing histamine spasm, and still less
effective in abolishing acetylcholine spasm (Rapport
and Koelle, 1953). Mepyraialne in a dose which
protects guinea-pigs completely against dyspnoea
caused by histamine, has no effect against a similar
condition produced by 6-hydroxytryptamine (Herxheimer,
1953), Other antihistamines wore tested by Page
and McCubbin for anti-5-hydroxytryptamine effects,
but such effects as were recorded were not clear-
cut, (Page and McCubbin, 1853b).
Metabolism of 5-hydroxytryntaraine.
It has been known for some time that
tissue homogenates destroy the activity of extracts
containing 5-hydroxytryptamine (Ersparaer, 1943b)
ana that amine-oxidase destroys 5-hydroxytryptamine
(Blaschko, 1952). Recently, the work of Ek and
Witkop (1953) and of Udenfriend, Clark and Titus
(1953) enable the following table of 5-hydroxy¬
tryptamine/
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(a) Ek and Witkop found 5-hydroxy-
tryptophan to be quite stable to kynurenlne-forming
enzymes.
(b) This decarboxylase would not de-
carboxylate tryptophan$ thus tryptophan >
tryptamine > 5-hydroxytryptamine is very unlikely.
5-hydroxytryptaraine/
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6-hydroxytryptaiuine is 6-hydroxyindole-acetic acid.
This was shown to be a normal constituent of the
urine of carnivorous and omnivorous animals, (Titus
and Udenfriend, 1964; Erspamer, 1966).
Chemical properties of 5-hydroxvtry?tamine.
Since Erspamer studied the staining
reactions of the enterochromaffin cells, he has made
frequent use of colour reactions in his work on
enteraiaine (5-hydroxytryptanine) in solutions and on
chromatograins (Erspamer and Boretti, 1961; Vialli
and Erspamer, 1940, 1942).
Two of his tests are the following -
1) coupling reaction in acid medium.
Reagent - 20 vols, saturated frozen
solution of p-nitraniline in
0,06 N hydrochloric acid and
1 vol. of 1% sodium nitrite.
If this is used to spray a
chromatogram enteramine A and
enteramine I spots will give a
yellow-red colour, becoming
peach-red later and being very
persistent. If the reagent is
added to a solution containing
either/
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either enteramine A or
enteramine I, a wine-red
colour can be extracted from
the mixturej by shaking with
amyl or butyl alcohol. The
intensity of the colour in
this alcohol layer is pro¬
portional to the concen¬
tration of enteramine.
2) Enteramine in alkaline media gives a
yellow or gold-yellow fluorescence in
Wood's light.
This latter ability of 5-hydroxytryptamine
to cause fluorescence under certain conditions led
Shepherd, West and Erspamer (1953) to quantitative
detection of 6-hydroxytryptamlne on chromatograms.
They used butanol, acetic acid and water for their
chromatography solvent, and sprayed the dried papers
with a mixture of potassium aichromate solution
and formaldehyde. After heating the papers at 100-
110°C for 5 minutes, the spots caused by 5-hydroxy¬
tryptamine showed a golden-yellow fluorescence when
viewed under ultra violet light. This method is
quantitative/
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quantitative as low as 0.2 jig 5~hydroxytryptamine
base. Bufotenin© and bufotenidine behave quite
similarlyj but the test is much less sensitive
to tryptamine.
Jepson and Stevens (1853) published a
fluorimetric test which is specific for certain
tryptamines, including 5~hydroxytryptamine and
tryptamine itself.
A chemical method for the estimation of
5-hydroxytryptaaaine in platelets was developed by
Udenfriend andWeissbach (1854). This method is
based on the fluorescence intensity arising when
6-hydroxytryptamine is activated at 295 mp ana
fluoresces at 330 sip (Udenfriend » 1954).
Synthesis of 5-hydroxytryptamine.
Asero, Colo, hrspamer and Vercellone
(1952) synthosised 5-hydroxytryptamine and isolated
it as the pierate. The outline of their method is
as follows -
m-cresol—> 2-nitro 5-oxytoluol —> 2-nitro
5-methoxytoluol —> 2-nitro 5-methoxyphenyl pyro-
racemic acid—> 5-methoxyindole carbonic acid—>5-
methoxyindole ^ s-metiioxy indole &ceto--nitpile >
5 methoxytryptamine HC1 —>5-hydroxytryptamine HC1.
Hamlin,''
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Hamlin and Fischer made their synthesis in
1951, thus -
5~benzyloxyindole —> 5~bensyloxygramine
5-benzyloxyindole 3-acetamide —> 5-benzyloxytrypta-
mine—> 6-hydroxytryptamine HC1. This product was
described as a light sensitive hygroscopic salt.
At the same time Speeter, Heinzelmann and
Weisblat (1951) aynthesised 5-hydroxytryptamine
creatinine sulphate, also from 5-benzyloxyindole,
in this way, -
5~benzyloxyindole —> 5-benzyloxyindole
aceto-nitrile —> 6-benzyloxytryptainine HC1 —> 5-
hy&roxytryptamine creatinine sulphate.
Speeter and Anthony (1954) have developed






Paper chromatography as we
•understand it "&o-&ay, was first used by Consden,
Gordon and Martin (1944). It is thought to depend
on differential partition between two solvents,
which on paper means a partition between the
stationary phase of the cellulose and adsorbed water
and the mobile phase of the organic solvent.
Here, the ascending method of paper chroma¬
tography was used. The distances moved by adrenaline
and 5-hydroxytryptamine under the influence of
various solvent systems was studied.
The components of the chosen solvent were
mixed 12-16 hours before required ana placed in a
separating funnel. If there was a separation into
layers, the aqueous layer was rejected and the
solvent, (i.e. organic) layer was placed in the
tank. Large rectangular glass tanks, (20 cm. x
30 cm. x 40 cm.) with plate glass covers were used.
A/
Top.




Diagram of method of ruling a sheet of chromatography
paper for determination of Rp values of five test solutions (a-e).
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A sheet of Whatman Ho.l (Chromatography)
Paper 39 cm. x 36 cm. was ruled as shown} and the
+
test solutions spotted in their appropriate place.
When the sheet was dry it was made into a cylinder
by sealing the long edges with cellotape. This was
set upright into the solvent in the tank. The
glass plate was placed on the tank and an airtight
.
seal made with vaseline. The tank was protected
from light by thick brown paper.
.
After 18-24 hours, development was stopped
and the paper hung out to dry at room temperature.
The adrenaline/noradrenaline strip was cut off, also
the preparation P.strip. The first was sprayed with
potassium ferricyanide reagent, the second with
Pauly reagent and the remaining (indole) strips
were sprayed with Ehrlich's reagent.
When the position of the spots was clear the
distance/
+Test solutions Concn, Vol. used
Adrenaline and nor¬
adrenaline aa 6 mgm/ml in 0,OIK HC1 0.006 ml.
Tryptamine HC1. 6 mgm/m1 in water 0.006 ml.
6-hydroxytryptaiiiine 6 lagm/sl in 0.01H HC1 0.006 ml,
A preparation of
Tryptophan 5 mgic/ml in 70$
Top.
1-5 1-5 4 1-5 3 c m.
30cm.
sample sample con trol 5 cm.
Bottom.
Diagram of method of ruling a sheet of paper for
chromatography of two samples of serum with a control
spot of 5-hydroxytryptaraine.
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distance from the starting line to each was
measured arid taken as a ratio of the distance to
the upper limit of the solvent, (See table of Rp
values).
For quantitative work, the Whatman No#l
paper was first washed overnight by 0.01N hydro¬
chloric acid. This was done by arranging the paper
to hang from a trough, in which one end of the sheet
was submerged in the acid. The paper was then air-
dried and ruled as shown. The samples were placed
along the base-line of the wider strips while
control spots of 6-hydroxytryptamine solution con¬
taining about 2 pg 5~hydroxytryptamine were placed
on the base-line at the centre of a narrow panel.
When thoroughly dry the sheet was sealed into a
cylinder by ceilotape and placed, standing upright,
in the solvent at the bottom of a tank. The tank
was closed, sealed and covered as before. After
18-24 hours, the paper was taken out and hung up to
dry - in air at room temperature. When completely
dry, the narrow (or control) strips were cut off and
sprayed with Bhrlich's reagent. A purple-blue
colour indicated the position to which 5-hydroxy-
tryptamine had travelled, A strip-a_cm. wide was -
cut/
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cut from each sample strip, in such a way that Its
centre was the same distance from the base-line as
was the control purple spot.
These strips were suspended from small
celluloid troughs - one end of the paper being held
between two glass microscope slides by a rubber
band. These slides were held within the trough
by a third slide. The trough was filled with
eluting fluid which slowly seeped down the paper
and was collected in a suitably placed glass tube.
All the troughs and tubes were arranged within a
small cabinet in which a beaker of water kept the
atmosphere moist.
In some cases, samples of 6-hydroxytryptamine
were placed on paper in imitation of a chromatogram,
where study of the efficacy of elution methods was
being tested. Here, portions of acid-washed paper
were cut 6 era, x 12 cm. and a solution containing
1 jig or 2 pg of 5-hydroxytryptaraine in 1 ml saline
was carefully pipetted on to each portion. These
were allowed to dry, in air at room temperature.
Amberiite resin. IRC 50,'
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Ainberlite resin« IRC 50
The cation exchange resin, IRC £0, was
ground to a fairly fine powder. Any very fine
particles which aid not settle within & minutes of
suspending the resin in water and stirring briskly,
were discarded.
100 mgu. portions of this fairly fine powder
were taken and suspended in R/IG sodium hydroxide.
Then they were transferred to fine glass tubes - 3mm
internal diameter and 13 cm. long,(column height,
2 cm,)-one end of which had been constricted and
drawn to a short tip. This tip was plugged with
cotton wool and the resin allowed to settle above
the wool. The tightness of the packing of the
wool, together with the height of fluid in the tube
determined the rate of flow of the solution. The
tubes, already containing the resin were generally
placed in phosphate buffer, pH 7, overnight.
During the use of the columns, the rate of
flow was adjusted as far as possible by the height
of the column of fluid above the resin. The




The apparatus consisted of a large
desiccator joined by a wide bore (1.5 cm) glass
tube to two glass traps in series. The second of
these was attached to a vacuum pump and motor by a
similar tube. Both the glass traps /ere suspended
in thermos jars and packed Into these with a
I ; !
freezing mixture of solid carbon dioxide and acetone.
Cotton wool was used to cover this mixture and the
tops of the traps which projected above it.
Samples of solutions to be fpeeze-drled were
run into MacCartnev bottles which had been cooled
in a solid carbon dioxide and acetone mixture. The
tubes were rotated as the sample was run in so that
the latter froze in a thin, film over the wall. The
.
tubes were then covered with a gauze and placed in
.
the desiccator. All joints in the apparatus were
sealed with vaseline. The pump was started and
after the air was expelled the system was closed.
When the samples were quite dry., air was let into
the system slowly and the desiccator opened. Screw
caps were placed at once on the tubes and these were
stored at -17° until required,
Bxt^raqtioh^
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Extraction ofJ3-,hydroxytryptamine from tissues.
Amin (1954) and Amin, Crawford and
Gaddtmi (1954) have studied the quantitative extraction
of 6-hydroxytryptamine from the brain of the dog.
They found the best results with a double extraction
of the tissues with 95/ acetones i.e. first extract¬
ion: 20 ml A.R. acetone/g tissue; second extract¬
ion: 20 ml 95/ acetone/g tissue. This removed all
the extractable 5-hydroxytryptaifdne in solution in
the acetone and left the substance P in the insolu¬
ble residue,
In detail the method was as follows - A dog
was anaesthetised with chloroform ana bled out.
Samples from the brain were placed in weighing
bottles and the weight of tissue determined. The
extraction of the smaller samples was made in these
bottles but the larger were transferred to bearers,
20 vols, A.R. acetone was added to each and the
tissue finely divided with scissors and pressed and
stirred occasionally with a flattened glass rod for
one hour. Each supernatant was filtered through
Whatman ^o.i paper, which had been washed with 5 ml
95/ acetone. when the filtration of the extracts
was complete, the papers were each washed with 2 ml
95//
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95# acetone. To each of the residues was added
20 vols, of 95# acetonG? these were again stirred
and pressed, for half-an-hour. The supernatants
were filtered, each through the same paper as before
and the precipitates were transferred to their
respective paper. The bottle, or beaker, and
precipitate were washed with 2x5 ail 95# acetone.
The combined acetone filtrates were evaporated to
dryness, under reduced pressure at 30-35°C.(2 ml
ethanol was added when necessary to reduce frothing)
One ail water was added to each residue and this
was extracted twice with 10-15 ml petroleum ether
(b.p, 4G~6CuC), to remove lipids. The aqueous
residue was again evaporated to dryness under
reduced pressure, at 30-35°C. The extracts were
stored overnight at -17°G, and assayed- if possible,
on the next day, occasionally not until the following
day.
1) extraction of rabbit tissues.
Since clotted rabbit blood has
a high 6-hydroxy tryptamine equivalent >( i.e. high
serum - 5-hydroxytryptaraine content compared with
other animals - Erspamer, 1954a and b), efforts were
made/
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made to remove as much blood as possible from the
tissue before sampling.
A rabbit was anaesthetised with ether and its
chest was opened. The aorta was cannulated and per¬
fusion of about 1 1. of saline was made at about
60 cia. water pressure. Blood and perfusate were
allowed to escape by an opening in the inferior
vena cava.
When samples from the head and neck were
required, the carotid arteries were cannulated and
the saline perfusion allowed to escape by the
jugular veins.
The pulmonary artery was cannulated when
lung samples were required. In one case where this
was done a series of samples of perfusate was
collected throughout the perfusion. They were
later calibrated eolorimetrically in terms of the
first sample - this showed that when the tissue
appeared creamy-white and bloodless, and the per¬
fusate was almost colourless, this perfusate con¬
tained less than X% of blood, therefore the tissue




Thus when the perfusate was clear, samples
of tissue were taken, weighed and extracted. If
there was any delay in dissection, e.g. while the
skull was being opened for the brain, any other
tissue samples already collected were kept at -17°C
The extraction method was as for the dog
brain samples, but tough, or dense, tissues, e.g.
skeletal muscle, diaphragm, heart, were cut up
under acetone and then rubbed in a glass mortar
with silver sand. Extraction was completed as
before. (See p.46). On two occasions, after the
perfusion with saline was complete, electrodes were
placed on the spleen and stimulation was applied
until the organ \<ras quite contracted. It was then
removed, weighed and extracted vrith acetone.
In sampling the gut mucosa, the whole
stomach and intestines were removed, and separated
into stomach, upper half of the small intestine,
lower half of the small intestine, and large
intestine. Each portion was slit open throughout
its length and washed under running tap water.
When clean it was blotted dry with filter paper.
The whole mucosa of each area was scraped gently
off with a blunt scalpel, and extracted? then
50
an aliquot of the acetone extract was evaporated to
dryness, and the treatment completed as before.
leg vein of a trained unanaesthetised dog. About
60 ml was collected in each experiment. It was
allowed to run directly from the intravenous needle
into a clean dry measuring cylinder. In one case,
blood was taken from a chloroform anaesthetised
dog, just as it was being prepared for another
experiment.
Clots were broken up with a glass rod, and,
10-20 minutes from the end of collection, the blood
was placed in a centrifuge tube and spun at 3,500
r.p.rn. for 10 minutes.
Samples of 2.5 ml or 5 ml serum were
measured into dry flasks and to some was added a
small volume of saline containing either 1 pg or
2 jig 5-hydroxytryptamine, and to the others a
similar volume of saline. 20 volumes of acetone
were added and after being thoroughly shaken the
flasks were stored at 5°C for half-an-hour. The
extracts w-ere filtered off through acetone-washed
papers and the flasks and precipitates were
2) Extraction of serum.
Blood was obtained from the
with/
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with 2 x 10 ml 95# acetone. (Extraction of the
residue with 95# acetone was considered unnecessary
for serum, blood or bile). After evaporation of
the extracts to dryness, the residues were taken
up in water and the lipids removed as before.
The extracts were again dried, and stored at -17°C.
A sample of rabbit serum obtained from blood
removed under ether anaesthesia, was similarly
extracted, but without the addition of standard
5-hydroxytryptamine.
anaesthetised with ether (I) and the other with
urethane (II), A polythene cannula was inserted
in the carotid artery and the free-flowing blood
collected into a siliconed tube.
(I) The blood was immediately measured in
1 ml portions by means of a siliconed pipette into
each of two siliconed flasks (A and B) already con¬
taining 20 ml A.R. acetone, two dry siliconed
flasks (C and D) and two dry glass (i.e. not sili¬
coned) flasks (E and F),
The blood in A and B never clotted and
extraction was continued at one© by shaking and
storing at 5°C for one hour, followed by filtration
3) Extraction of blood.
Two rabbits were used} one was
etc,/
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etc. as in the serum method (p. 50).
The samples in E and F clotted almost
immediately but C and D stood for about five hours
at room temperature before the clotting was complete*
These four samples were then extracted with 20 nil
A.R. acetone each, stored at 5°C for an hour.
Subsequent treatment followed the technique already
described for extraction of serum (see p.50).
(II) Three samples of 1 ml blood were each
measured directly into 20 ml A.R. acetone, and two
into dry non-siliconed glass flasks. The latter
samples clotted and after one hour 20 ml A.R.
acetone was added to each of these. All the samples
were stored at 5°C for an hour and subsequent treat¬
ment was as for serum extraction (see p.50).
Biological preparations
1) The isolated rat uterus - Method for
assay.
During the past few years it has been
apparent that the isolated oestrous uterus of the
rat can be a sensitive, regular test organ for 5-
hydroxytryptamine.
Erspamer first discovered the suitability of
this/
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this test organ and prepared his rats in oestrous
by ovariectomy and, 20-30 days later, injection of
50-100 pg oestradiol dipropionate as one dose or as
two divided doses. The rats were best used 5-7 days
from injection (Erspamer, 1942aj 1952a).
In this laboratory, virgin rats of 160-200 g
were injected subcutaneously with 100 pg/kg of
stilboestrol (solution for injection contained
100 pg stilboestrol/ml in arachis oil), 20-24 hours
before being required for the experiment,(Amin,
Crawford and Gaddum, 1954),
Next day, the rat was killed by a blow on the
head and its throat was cut. The uterus, with
adhering adipose tissue was carefully removed. The
latter was trimmed off and most of one horn (i.e.
about 2 cm relaxed length), was ligatured at both
ends, attached to a hook and suspended in a 2ml
bath,
+
It was immersed in de Jalon solution, con-
6
taining 10" atropine, at 28-29°C. After being set
up the uterus generally relaxed slowly for about
half-an-hour. The lever was then adjusted to bring
the/
+
Modified - Gaddum, Peart and Yogt,(1948).
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the arm bearing the writing point to an angle of
about 10° below the horizontal. Dosing with
5-hydroxytryptamine was begun, and with a
magnification of 10-12 x and a tension of 0.6-1.0 g.
the range was usually between 2-6 ng (minimum
response), and 20 ng (maximum response). Doses
were repeated regularly at a 4 or 5 minute interval?
and assay was made between 5 and 20 ng 5-hydroxy-
tryptamine where the discrimination was - 1-2 ng.
2) The isolated perfused ear of the
rabbit.
The isolated ear of the rabbit
was perfused in a manner similar to that used by
Gaddura and Kwiatkowski (1938), and by Gaddum and
■■
Hameed (1954).
The rabbit was killed by a blow on the back
of the head and its throat was cut. The ears were
removed, as close to the skull as possible, and
placed in physiological saline. As quickly as
possible, the central artery was identified and
dissected free from adipose tissue and fascia for
about an inch of its length. A sraall polythene
cannula was filled with saline, inserted into the
artery and ligatured in position. The ear was
washed/
Figure 1
APPARATUS FOR PERFUSION OF THE
ISOLATED EAR OF THE RABBIT.
Apparatus for the perfusion
of the isolated ear of the rabbit.
Note the two reservoirs, which enable the supply
of alternative perfusion fluid to be easily made?
the injection cannula, which is described in the
textj and the drop recorder, which measures the
rate of fluid-outflow from the ear.
INJECTION CANNULA
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washed free from blood in the perfusing system while
the second ear was similarly prepared. As soon as
the perfusate was colourless, the second ear was
washed free from blood. After this the ears were
stored in a beaker of saline at 5°C for 3-4 days.
Normally one ear was used on the day after dissect¬
ion and the other on the following day.
The perfusion system comprised two reservoir
bottles which could be raised to almost 1 m. above
the platform on which the ear was mounted. Both
these bottles were connected by an X-junction to the
injection cannula and through it to the ear.
The injection cannula was designed so that
the injected dose would reach the ear with as little
dilution as possible, and also, that it would all be
washed quickly into the ear. The flow from the
reservoir passed dropwise into the cannula and thus
the injection rate could easily be of controlled
pressure, to be equivalent to the reservoir pressure.
If the injection was made too slowly, drops of
saliue would also pass into the cannulaj if too fast
the saline would be pushed back up the tube by the
excess pressure. Thus injections were made at such
a/
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a rate that a hanging drop was held in position.
The venous outflow from the ear was collected
on the supporting plate and allowed to run into a
small funnel from which it was led to a drop-timer.
This was arranged to record, on a smoked drum, the
interval between successive drops. The higher the
stroke, the longer was the interval! thus vaso¬
constriction was recorded as a peak.
The perfusion fluid was that recommended by-
Page and Green (1948), for use in the study of
serum vasoconstrictor.
Composition of Page solution.
Sodium chloride 0,82^
Potassium chloride 0.084>£
Calcium chloride, 2HSG 0.0G4;£
Magnesium chloride, 6Ha0 0,006^
Sodium bicarbonate 0.04^
Glucose 0,1%
To each litre of this solution is added 10 ml
phosphate buffer prepared by mixing M, Potassium
phosphate (4 vols.) with M. Potassium dihydrogen
phosphate (1 vol.)
When perfused with Page solution, the
sensitivity of the ear vessels to 5-hydroxytrypta-
rnine was 1-20 ng. in a volume of ^ 0.2 ml saline.
3/
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3) The heart of Mactra Solida - Method
fQE assay.
Twarog and Page (1953) have used the heart of the
quahog, Venus mercenaria, for the estimation of 5-
hydroxytryptaraine in tissue extracts. This mollusc
is not found in British waters, hut a survey of some
of the molluscs available here has heen made by
Paasonen (1954). He has shown the heart of Mactra
solida to be a suitable preparation, at least in the
late summer and autumn months. This cockle lives
below the low tide level and has been obtained from
the sea-bed near St, Andrews, Fife, The molluscs
were best stored in sea-water at about 10°C.
One shell of the bivalve was removed and the
heart could be clearly seen. A thick walled ventri¬
cle is flanked on either side by very thin walled
auricles. Ligatures were placed round each of these
aurlculo-ventricular junctions, "By means of these
ligatures, after the ventricle was dissected free
from the auricles and aorta, the heart was suspended
in a 2 ml organ bath, attached to a hook and a very
light recording lever.
The heart is very sensitive to stimulation by
5-hydroxytryptamine and inhibition by acetylcholine}
but/
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but the acetylcholine effects can be abolished by
_3 .5
the use of 10 - 10 mytolon in the bathing
fluid. (This bathing fluid is a physiological
saline having the ionic concentrations of sea-water).
The heart is relatively insensitive to adrenaline,
1 jxg being required to produce a stimulation where¬
as 1-2 ng of 5-hydroxytryptamine always caused at
least a threshold stimulation. The discrimination
was 0,5 - 1,0 ng 5-hydroxytryptamine/2 ml fluid.
J
Some extracts of dog brain samples were
kindly assayed by Dr. Parsonen on this preparation
in parallel with assays on the rat oestrous uterus.
4) The isolated guinea-pig ileum.
A young guinea-pig, weighing
150 g was fasted overnight. It was killed by a
blov; on the head and its throat was cut. The
portion of ileum nearest the caecum was dissected
out and washed through with Tyrode solution. A
piece,about 1.5 cm,was suspended in a 2 ml organ-
7
bath in Tyrode solution containing atropine (10" )
and mepyramine (10 ), at 37(JC. The responses
were recorded by a light frontal writing lever
giving a magnification of about ten times.
Preparation/
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Preparation of mushroom .juice.
The acetone extracts of the tissues
contained some proportion of adrenaline, which
caused interference i^lth the assay of their 5-
hydroxytryptamine content, for while the latter
caused a stimulation of the isolated rat oestrous
uterus the former caused an inhibition. Adrenaline
is an ortho-dihydroxy compound and 5-hydroxytrypta-
mine is a monohydroxy structure. Thus it was
thought that an enzyme which would specifically
oxidise di~ or polyhydroxy compounds might be used
for the routine treatment of the extracts before
their assay.
Keilin and Mann (1938) detailed the prepar-
ation of a polyphenoloxidase from edible mushrooms -
its purification, nature and properties. It had a
comparatively high specificity, speedily oxidising
ortho-dihydroxyphenols, but few monophenols.
Ten years later Mallette, Lewis, Ames, Melson
and Dawson (1943) described the purification of a
similar enzyme preparation, also from mushrooms.
This/
+
Psalliota (or, Agaricus) campestris - somewhat
vation.
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This polyphenoloxidase, -which is also known
as tyrosinase (Sumner and Myrb&ck, 1952$ Sumner
and Somers, 1953) occurs in bacteria, potatoes and
mushrooms as well as in human skin and melanomata.
It is an aerobic oxidase, containing copper, which
converts catechol to o-quinone as the first step in
the formation of melanin.
Preparations of this polyphenoloxidase possess,
also, an action on monophenols. This latter activity
is apparently linked to the other active entity but
is less stable. For example, heating at 60°C
reduces the activity of both, but of the mono-oxi-
dase more than of the polyoxidase (Adams and Nelson,
1938). Various other treatments can alter the
polyoxidase/mono-oxidase activity ratio. Both the
purification methods referred to above were designed
to give a high polyoxidase-active product,
Keilln and Mann (1938) stated that even a
crude extract of mushrooms oxidised with great
velocity, mainly ortho-dihydroxyphenols,and but few-
monophenols. This difference in oxidation rate of
mono- and di- phenols was largely that of a more, or
less, protracted lag period.
In the present work, edible mushrooms were
chosen/
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chosen as a convenient source of the enzyme for
they are easilj^ available and are free from the
large quantities of starch which occur in the
cheaper source* potatoes.
120 g of fresh mushrooms were sliced and
then ground in a household mincer. The pulp was
rubbed in a mortar with about 10 g silver sand for
20 minutes. The juice was squeezed out through
linen, by hand, (No water was added). This
yielded 80 ml of a dark brown turbid fluid, which
was slightly frothy. It was stored at 5°C.
A one*in-ten dilution of this crude juice
was used in the investigation of its activity.
Later, a larger quantity of juice was
prepared in an exactly similar way. After storage
at 5°C overnight - reported by Keilin and Mann
(1938) often to cause an increase in activity, - a
portion of it was distributed as 0,5 ml samples
into a number of small test-tubes. These samples
were freeze-dried by reduced pressure, in a centri¬
fuge over phosphorus pentoxide.
When the juice was completely dry, the tubes
were sealed and stored at 5°C, The residue was
like a solid foam and was brown in colour. It re-
dissolved readily to give a slightly turbid
solution./
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solution. One tube provided sufficient enzyme
activity for the treatment of about eight samples
of tissue extract.
This dried preparation of mushroom juice
will be referred to later as the standard
preparation of crude mushroom juice.
The remaining crude juice was divided into
two parts and each was subjected to a simple
purification, for the crude juiice contained a con¬
siderable amount of coloured material. Some of
the juice was dialysed in a cellophane tube (thick¬
ness^. 0025mm) , against slow flowing deionised
water - 10 A. in 24 hours. A little coloured
matter passed out and the volume inside the tube
was increased by The rest of the juice was
filtered through Whatman No,41 paperj a small
residue was held back.
Samples (0,5 ml) o.f the dialysed, and of the
filtered juice were dried and sealed as before.
With allowance for the dilution of the dialysed
portion, neither of these portions showed any
increase in activity or greater specificity then






The earlier part of this study
was done on the assumption that extracts? prepared
from tissues with acetone (see p.46) would be
subjected to paper chromatography as the final
stage of their purification. This was to be done
with the aid of a solvent which would give such a
separation of adrenaline from 6-hydroxytryptamine
that the portion of the developed chromatogram
carrying the 6-hydroxytryptamine could be eluted
to give a sample free from adrenaline.
All the assays in this section of the work
were done on the isolated oestrous uterus of the
rat, prepared and set up as described on p,
Samples of 5-hydroxytryptainine were placed on
6 x 12 cm, portions of "Whatman Ho.l paper? previously
washed with 0,Q1N hydrochloric acid, in imitation of
a chromatogram and various means and solvents were
tried to achieve their satisfactory quantitative
removal. It was found that a slow, flowing elution,
from/
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from a small trough down the paper, yielded, in
about 22 hours, 6-8 ml of eluate which contained
70-100^ of the added 6-hydroxytryptamine. To deter¬
mine the progress of the 6-hydroxytryptamine down
the paper, a spot of concentrated (4 jxg/0,04 ml),
5-hydroxytryptamine solution was placed at the
top of a number of portions (6 x 12 cm) of paper.
These were eluted with 0.01N hydrochloric acid for
various intervals, 2 hours, 16 hours and 22 hours J
then the papers were removed, and dried. They were
sprayed with Khrlich*s reagent, and the presence of
a blue-purple spot on the *2 hour* and *16 hour*
paper and its absence from the *22 hour* paper showed
that in the latter case the |>-hydroxytryptamine was
completely eluted. In a *contact * elution where
the whole strip was shaken in a stoppered tube with
14-16 ml eluting fluid, 60-80?< recovery was obtained
with 1 hour contact. The solvent in these eases
(i.e. eluting fluid) was saline or 0,01H hydrochloric
acid, in which the 6-hydroxytryptamine was found to
be stable at room temperature for at least 24 hours.
Samples of 1 pg and 2 pg 6-hydroxytryptamine were
used/
'Ehrlieh's reagent - (blue-purple colour with
indoles). 1 g p-dimethylaminobenzaldehyde in 16 ml.
ethanol and 16 ml cone, hydrochloric acid.
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used and the activity estimated without dilution,
but should the extracts contain less 5-hydroxy-
tryptamine activity, the eluates would require to be
concentrated.
Evaporation of the saline eluates under
reduced pressure at 37°C yielded less than 10$
recovery. No improvement was found by lowering the
temperature to 20°C. Simple neutralisation of the
acid eluates with sodium bicarbonate, before evapor¬
ation was not satisfactory. The recoveries were
never greater than 25$.
Since the recovery is satisfactory when
5-hydroxytryptamine is added to tissue extracts and
these are evaporated, 5-hydroxytryptamine was added
to a tissue residue containing negligible 5-hydroxy¬
tryptamine 5 the mixture was acidified, neutralised
with bicarbonate and evaporated under reduced
pressure. The recovery was 60-100$; similar results
were obtained by the addition of 1 jig or 2 p.g
lecithin to acid eluates.
It seemed at this time that this problem was
more complicated than it had at first appeared. So,
for a time, investigations were continued on the
behaviour of simple dilutions of 5-hydroxytryptamine
W
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in 0.01N hydrochloric acid, (i.e. no contact with
chromatography paper). Since the recovery of
5-hydroxytryptamine fell as soon as evaporations
were made, it was thought that heavy metal ions,
possibly present in the water, were promoting
oxidative destruction of the 5-hydroxytryptamine.
BAL - dlmercaprol, which was shown by Bacq,
Fischer and Lecomte (1948) to protect adrenaline
from air oxidation and dithiocarbamate, another anti¬
oxidant, were each added to samples, but the
recoveries after evaporation were inconsistent.
Various buffers were used to stabilize the
pH at different levels, during evaporation. It
was found that a few drops of 0.2 M. sodium phos¬
phate buffer, used to give pH 6.5 gave the most
satisfactory recoveries. The recovery estimates
were made on the oestrous uterus of the rat. It was
noted at this time that the pH of the sample at
assay was partially responsible for the height of
the uterine response. If the test sample was more
acid than pH 4.5 the contraction elicited is not so
great as the concentration of 5-hydroxytryptamine




pH to 6*5 and re-assay. (If the pH is more
alkaline than pH 8, 5-hydroxytryptamine activity
is lost, for it is unstable in alkaline media).
The addition of lecithin, and the use of
phosphate buffers were then tried with the eluates
of 5-hydroxytryptaraine from the paper. It became
clear that something else was washed out of the
paper - this compound speeded the destruction of
5-hydroxytryptamine during evaporation, or formed
a complex with it to reduce its activity on the
uterus. Other types of paper, Whatman Nos, 3 and 4,
were tried and various methods of pre-treating the
paper were employed. These includedt-
a) washing the paper with 0.01 N hydro¬
chloric acid for 48 hours before use (in¬
stead of the usual 12 hours), or
b) washing the paper with ascorbic acid
solution (50 mgm/100 ml.) or
c) washing the paper with ¥ersene solution
(ethylenediamine tetra-acetie acid, used
by Eggleston and Hems (1052) in chromato¬
graphy and believed to remove traces of
metal impurities); or
d) washing the paper with 0.01N sodium
hydroxide, before the usual acid washing.
No/
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Ho significant improvement in the recovery
of 5-hydroxytryptamine from paper treated in any
of the above ways was found.
Vialli and Erspamer (1942) recognised a
substance in their 5-hydroxytryptainine extracts of
tissues, which gave the colour reactions of
5-hydroxy!ryptaaine but had not the pharmacological
activities of the latter. They found, however, that
heating to 1Q0°C at pH 7 for 10 minutes resulted in
the appearance of pharmacological activites typical
of 5-hydroxytryptamine. The treatment had there¬
fore changed the »enteramine I*, or 'inactive entera-
raine\ into 5-hydroxytryptamine, or enteramine. It
was suggested that during these chromatographic and
evaporation procedures, some of the added 5-hydroxy¬
tryptamine was being changed into an inactive form.
So certain samples were placed at 100°C at pH? for
10 minutes but increased recoveries were not found.
For a time, evaporation was abandoned and




Araberlite resin 1HC SO
It had been found by Fingl (1963)
that 5-hyaroxytryptainine could be adsorbed on the
cation exchange resin 1RC60, from a solution of
pH 6-7 and could then be eluted by 0.1N hydro¬
chloric acid. Here it was proposed that a similar
method should be used for the concentration of
eluates from paper chromatography, as an alternative
to evaporation.
Preliminary experiment
60 mgra of fine lPiC 60 was packed into a
tube, as described on p.44. Sodium phosphate buffer,
0.2 M and pH 7, was passed until the effluent was
also pH 7, Then 100 pg 6-hydroxytryptamine base,
in the same phosphate buffer was passed through
the column at 0.2 ml/minute. The drops of the
percolate, wash fluid and eluate, as they issued
from the chromatogram tube were applied in
succession as individual spots along a strip of
Whatman Ho. 1 filter paper. The column was washed
with 1 ml water and eluted with 2 ml Q.1H hydro¬
chloric acid. The strip of paper was dried and
then sprayed with Ehrlich's reagent (see p. 64).
This showed that only the first part of the
6-hydroxytryptamine/
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5-hydroxytrptamine had been adsorbed, for the first
portion of the percolate gave a negative reaction,
while the later part was positive. That is, after
a certain time the column was saturated and could
adsorb no more 5-hydroxytryptaiaine. However, the
wash-water gave a negative reaction and only the
first ml of acid eluate was positive. Thus the
water-wash did not remove the adsorbed 5-hydroxy-
tryptamine and what 5-hydroxytryptamine had been
adsorbed was eluted by the first ml of 0,11? hydro¬
chloric acid.
In subsequent work, owing to the lower con¬
centration of base and salts in the samples, after
the columns had been buffered with sodium phsophate,
0,2 M, buffer, they were washed through with 0.02 M
buffer of the same pH, Then about Q.b ml 0.2 M
buffer was used to bring the samples to the same pH
as the columns - these samples were now about
0.02 M.
In a few cases, the resin was not used in a
column, but weighed amounts of resin were stirred
with the samples, previously adjusted to the desired
pH. The fluid was then decanted off, the resin was
washed with water and then the resin was extracted
twice/
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twice with 0.1N hydrochloric acid.
Comparison of the two methods showed the
column method to be more satisfactory.
The recovery results from these experiments
are given below. Here the samples of s-hydroxytryp-
tamine were dried onto portions of chromatography
paper. These were eluted by contact and shaking with
14 ml 0.01N hydrochloric acid for an hour. A 12 ml
aliquot of each eluate was taken and adjusted to
pH 6.5, One of these eluates was reserved at 5°C
as a control while the rest were passed through
100 mgia columns of IRC 50 (prepared at pH 6.5) , and
the columns were eluted with 1 ml 0.25 H and 0.5 ml
0.01 N hydrochloric acid.
TABLE I
Recoveries from concentration of eluates from
paper by passage through columns of IRC 50.
Paper eluate, control - Eluates from paper
Expt Recovery of 1 pg and columns.
No. 5-hydroxytryptamine Recovery of
5-hydroxytryptamine
2pg l^g O.Sjig
I 60% 83% 36% A6%
II — 13% 43/£ 13%
III 17% 30% 60% 30%
These results were considered to be not
sufficiently consistent for routine work.
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Freeze-drying
A method of freeze-drying was
examined as an alternative to evaporation at <40°C
under reduced pressure, or passage through IRC 50
columns, for concentration of chromatogram eluates.
A model experiment was done with various
volumes of a solution of sodium chloride, of about
the same molarity as the neutralised eluates. After
freeze-drying, the residues were titrated with silver
nitrate solution and no significant loss was found.
It had been thought that perhaps there would be some
blowing out of the fine residue as the apparatus was
being opened, or perhaps some melting of the samples
and spurting of the solution, should the intensity
of the vacuum vary during the course of the
evaporation.
After several experiments, it was found that
if the tubes were very cold, (i.e. less than -60°C)
when placed in the apparatus, the drying process was
needlessly prolonged. Initial temperatures of
- 20°C to - 40°C were quite satisfactory. These
were obtained by mixing ice with the solid carbon




It was found, too, that the pH of the
sample at drying was very important to the recovery
of the 6-hydroxytryptamine activity. Therefore
samples were individually neutralised and buffered
■
at a pH meter (glass electrode) instead of, as
formerly, a control titration being done at the
meter and appropriate volumes of sodium hydroxide
and buffer added to the samples, The presence of
a buffer system seeraed quite essential and sodium
phosphate, (to give a pH of 6.5, as was found most
satisfactory during evaporation (see p,66 ) was
employed,) The recovery estimates were made on the
,
isolated oestrous uterus of the rat, and a number of
uteri were very sensitive to inhibition of
5-hydroxytryptamine contractions by phosphate, Vihere
this was the case, an equivalent concentration of
phosphate was added to the 5-hydroxytryptawine
standard solution and assays of samples were made
with reference to this.
The results of an experiment in which eluates
were freeze-dried after being adjusted to various





A number of samples of 5-hydroxy-
tryptamine \*ere taken » some were simply diluted
with 0,01 N hydrochloric acid, others were dried
onto Whatman No, 1 paper (previously washed with
0,01 N hydrochloric acid) and eluted.
In the second experiment, a control sample
was stored at 5°C during the time that the rest
were being freeze-dried, subsequent to pH adjust¬
ment of all the samples in the manner described
above.
Assays were made on the isolated oestrous







2 jig 1 p.g 0,5pg
Expt. I Diluted samples -
adjusted to pH 6.5
and freeze-dried. 58$ 47$ 47$
Paper eluate samples -
adjusted to pH 6.5
and freeze-dried. 47$ 45$ 54$
Expt. II Diluted samples -
as above, 84$
Paper eluate samples -
as above. 66$ 7g$ 35#ra
Paper eluate sample -
control.
adjusted to pH 6.5
and stored at 5°C
Underlined results obtained in comparison
With standard containing phosphate.
Next, samples of 2 pg and 5 pg 6-hydroxy-
tryptaiaine were chromatogrammed before freeze-drying.
In the first experiment, sec butanol, acetic acid
and/
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and water (4:ls5) was used as the chromatography
solvent. The appropriate strips were eluted with
0,01 N hydrochloric acid and the eluates were
neutralised and buffered at the pH meter as before
and then they were freeze-dried. The recovery of
5-hydroxytryptamine activity was very low, 25-30$,
and it was found that the pH of the samples, after
the addition of saline was 8-9. This must be
because of the loss through volatilisation of some
of the acetic acid which must have been in the
samples at neutralisation.
However, increased recoveries were again
obtained when n-butanol saturated with N hydro¬
chloric acid was used for the chromatography. Here
there was no »pH~shift».
This method was then used for 2,5-5 ml
samples of dog serum. Before extraction with
acetone, 2 pg 5-hydroxytryptamine was added to some
of them. Then acetone extracts were made and these
were defatted (see p.50 ), The dry residues were
extracted successively with 1 ml, 0,5 ml and 0.5 ml
of 75$ ethanol, and these extracts were placed along
the base-line of the sample portions of the 0.01 N
hydrochloric,
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hydrochloric acid washed chromatography paper.
Control spots of 5-hydroxytryptamine were also
placed on the base-line of the paper. (see p. 42 ).
When quite dry, the sheets were chroraato-
grammed in n-butanol saturated with N hydrochloric
acid. After 22 hours, the chromatograms were
removed and dried in air. The control strips were
sprayed with Ehrlich's reagent in order to deter¬
mine the position of the 5-hydroxytryptamine. The
corresponding areas of the sample strips were cut
out and eluted. Each sample was neutralised and
buffered to pH 6,5 at the pH meter and subsequently
frozen and freeze-dried. Assay of the 5-hydroxy-
tryptamine content of the residue was made on the
isolated rat oestrous uterus preparation.
The recoveries were low, 23-33^5 but the
results for 5-hydroxytryptaiaine content of dog
serum, when corrected for this loss, agreed
satisfactorily with results obtained later with
other methods.
Chromatography solvents tested.
In this work only the ascending
method of paper chromatography was used. The
results would possibly have been different had
the/
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the descending method, for example, been applied,
(see Discussion, p.105). With the ascending
method and a common solvent for adrenaline
chromatogram, phenol and hydrochloric acid,
5-hydroxytryptamine moved but little higher than
adrenaline. (Where the solvent travels 22-30 cm
the distance between the proximate edges of spots
of substances required to be separately eluted
should be at least 2.5 cm - a difference of at
least 0.1 HF in the absence of 'tailing*,)
Various solvent systems were tested and the
nearest approach to this ideal condition was given
by the solvent mixture sec-butanol, acetic acid
and water, in the proportion by volume of 4*1:5.
The spots were well defined. In some other
solvent systems the Hp difference was about the
same but the spots showed considerable 'tailing',
which is unsatisfactory.
Unfortunately, repeated chromatograms of
adrenaline and 5-hydroxytryptamine have shown the
separation, even in the sec-butanol, acetic acid
and water system, unsuitable for separate elution.
A/
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A table of the mean Rp values is given for
adrenaline, noradrenaline, tryptamine, 6-hydroxy-
tryptaraine, a preparation containing Substance P,
and tryptophan in the various solvent systems.
Solvent systems.
1. Phenol! glacial acetic acid!
waters :99!l:100.
2. n-butanol saturated with N hydro¬
chloric acid.
3. sec-butanol saturated with N hydro¬
chloric acid.
4. equal parts of n- and see- butanol,
saturated with N hydro¬
chloric acid.
6. n-butanol: glacial acetic acids
waterSS77S6J17.
6. sec- butanol! glacial acetic acid:
water::4:115.
7. n-butanol: sec- butanoltglacial
acetic acid: water::2:2:1:5.
8. tert-butanolsglacial acetic acid:
water: :4:1:5.
9. methylethyl ketone:glacial acetic
acid swater::4:1:5.
10. acetone: water::4:1,
11. 0,001 N hydrochloric acid.
TABLE III/
Notes on Table III - (see also Methodsp.41)
The Hp •value is the distance of a
particular point in the chromatogram frora the start¬
ing line expressed as a proportion of the distance
travelled by the solvent from the starting line.
The adrenaline and noradrenaline were placed
together at the same point on the starting line. In
some solvent systems these bases moved at the same
rate, in others they moved at different rates and
two coloured spots were apparent after the strip had
been sprayed with potassium ferricyanide reagent.
The tryptamine, 5-hydroxytryptamine and tryptophan
strips were sprayed with Ehrileh's reagent. This
gives a characteristic blue-purple spot with indoles.
In the chroraatogram with QQ% acetone, the 6-hydroxy-
tryptamine spot showed extensive *tailing» with
three areas of fairly intense blue-purple colour
after having been sprayed with Ehrlich's reagent.
The strip bearing Preparation P was sprayed
with Pauly reagent. A colour reaction is not,
however, necessarily indicative of the position of
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Effects of antagonists on the responses
of the Isolated perfused ear of the rabbit
When it seemed that chromatography
would not provide a suitable separation of i3-hydroxy~
tryptamine from adrenaline, attention was directed
to the isolated perfused ear of the rabbit. It was
hoped that under conditions produced by selective
antagonism, vasoconstrictor responses to adrenaline
and noradrenaline would be abolished while those to
5-hydroxytryptamine would remain unaffected. Thus
the Isolated perfused ear could be used under these
conditions as an assay preparation in place of the
isolated rat uterus; and the need for separation of
the adrenaline from the extract activity would not
be necessary.
During the experiments in which tests were
made of possible perfusion conditions suitable for
assay methods, one of the two reservoirs supplying
the ear was filled with a particular concentration
of an antagonist in Page solution. The ear was set
up (see p. 54 ) and perfused with Page solution for
2-3 hours. The perfusion rate was adjusted to be
about/
about 2 ml/minutej under a pressure of 30-40 cm
,
saline. Similar responses to adrenaline and/or
noradrenaline and 5-hydroxytryptamine were obtained-
dose interval = 6-12 minutes. Then the antagonist
solution was perfused, usually for about 20 minutes
before dosage was resumed. Kesponses were again
matched. From these matching responses the
sensitivity ratio adrenaline/5-hydroxytryptaraine,
and (or) noradrenaline/s-hydroxytryptamine,was found.
Under ideal conditions for this assay method,
the ratio,dose of adrenaline, dose of 5-hydroxy-
tryptamine for equal effects,is high, but the ear
vessels remain very sensitive to 5-hydroxytryptamine.
Ephedrine was the first drug studied. The results
of Gaddum and Hameed (1954) (see p.31 ) were con-
&
firmed. Ephedrine (1Q~ ) caused a sensitisation of
the ear vessels to both adrenaline and 5-hydroxy¬
tryptamine. The sensitivity ratio (see Table IV)
was little changed from that found with Page solution
_s
perfusion, Ephedrine (10 ) gave an inhibition of






















































































































































































































Perfusion of the isolated ear of the
rabbit, with Page Solution containing ephe-
drine (10"6)t
Height of record shows interval between drops.
This tracing illustrates a tachyphylaxis of the
vessels to 5-hydroxytryptamine, even with a dose




The ratio was increased. If the ephedrine concen-
tration was raised, (e.g. 10 ), responses to both
drugs were reduced and the ratio returned to its
.
previous low level. That is, the range over
several experiments of the ratio of the dose of
adrenaline to the dose of 5-hydroxytryptamine for
equal effects was -




for Page solution containing
6
ephedrine, 10"" , 0.4 - 2:
for Page solution containing
-5
ephedrine s 10** , 2 - 100 and
for Page solution containing
4
ephedrine,10" , 1 - 10,
Only on one occasion was tachyphylaxis to
responses to 5-hydroxytryptamine recorded in the
5
presence of ephedrine (10 ). Part of this
experiment is shown in Fig,2. Instead of the usual
ratio of 10 - 100, the ratio here was about one,
. .
(before tachyphylaxis).
To the optimum concentration of ephedrine
_5




















Chemical Formulae - Adrenaline
and certain adrenolytic drugs.
Figure 4
Perfusion of the isolated ear of the rabbit,
with Page Solution.
|Eph 10"5
1 HT 05HT 0-3Adr 0-5Adn 0-1 HT OSAdr 005 HT
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5Adr 4 HT 5Adr 5HT lOAdr 10HT
5-16 5*23 6-44 6*51 6-58 7*05pm
4-15 5-00
Doses in ng
Height of record shows interval between drops.
At 2,35 p.m, the Page Solution is replaeed5by
Page Solution containing ephedrine, 10"" :
At 4,15 P.m, ...sPage Solution containing
ephedrine 10- and piperoxane 5 x 10- :
At 6,00 p,m, ,,,3Page Solution containing
ephedrine 1G~ and piperoxane 10-3.
Note the changes in sensitivity of the vessels
of the ear to 5-hydroxytryptamine (HT) and
adrenaline (Adr) during the perfusion with
the various solutions.
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piperoxane. Their combined effect was to reduce
the sensitivity of the vessels to both the con-
6
strictors. Even with less ephedrine, (e.g. 10 ),
piperoxane did not produce a purely anti-adrenaline
effect. (The concentrations of piperoxane used,
corresponded to those used by Gaddurn and Hameed,
1954).
After a preliminary trial of regitine in
various concentrations it was apparent that it had
a definite anti-adrenaline effect though the ratio
f
was not increased markedly. Regitine (10" ) was
&
combined with ephedrine (10~ ) and this gave a lower
7
ratio than regitine (10~ ) alone had done.
Attention was then directed to the use of
ephedrine alone. In a few cases, this drug caused
a severe vasoconstriction and the experiment was
abandoned unless excessively high pressure for a
short time could cause a relaxation of the vessels.
Vfhen ephedrine 10 was perfusing satis¬
factorily the sensitivity of the preparation to
adrenaline was less than it was to 5-hydroxytryptamine.
In one experiment, the ear vessels were unusually
sensitive to 5-hydroxytryptamine and the constrict¬
ion. caused by an injection of this drug, was
followed/
Figure 5
0-1HT 0-05HT 0-1 HT
0*2Adr 0-1Adr
7-04 7-14 7-24 7-36pm
Doses in ng
Perfusion of the isolated e&i of the rabbit,
5
with Page Solution containing ephedrine (10" ),
Height of record shows interval between drops.
Bote the high sensitivity of this preparation
and the dilatation following the vasoconstriction
caused by S-hydroxytryptamine (HT), and by 5-hydroxy-
tryptamine together with adrenaline (Adr).
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followed by a marked dilatation. The same occurred
when a dose containing a mixture of adrenaline and
5-hydroxytryptamine was given ,(see Fig,5). In a
few cases, small doses of noradrenaline caused a
vasodila tation.
Again, in the presence of ephedrine, (10 ),
combined doses of adrenaline and 5-hydroxytryptamine
were injected and the responses compared with those
produced by the 5-hydroxytryptamine component alone.
Where the amount of added adrenaline was the same
(ng for ng) as the 6-hydroxytryptamine dose there
was only a very slight increase in the response over
that to the 6-hydroxytryptamine alone, whereas if
there was 2-4 times as much adrenaline as 5-hydroxy-
tryptamine in the dose, the response was much
increased. This was in spite of the fact that the
adrenaline dose, itself, caused only a small or
threshold response.
A similar effect was recorded with nor¬
adrenaline and 6-hydroxytryptamine in combined
doses, where the ear vessels were perfused with
ephedrine, 10"* , Here also, where the dose of
noradrenaline was equal to one third of the dose of
6-hydroxytryptamine (ng for ng) there was a slight
reduction/
Figure 6
Perfusion of the isolated ear of the rabbit
/ -s
with Page solution containing ephedrine (10 ),
0-15HT 0-15HT 0-15HT
1 Nor 0-5 Nor 0-5Nor











Height of record shows interval between drops.
Note that although the sensitivity of the vessels
of the ear is less to noradrenaline than it is to
5-hydroxytryptamine (sensitivity about 1/10), the
response to a mixture of these drugs is greater than
that to the 5-hydroxytryptamine component alone
where the proportion of noradrenaline to 6-hydroxy-
tryptamine is greater than 1 to 1.
Nor. noradrenaline. HT. 6-hydroxytryptamine.
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reduction of the response compared with that to the
5-hydroxytryptamine dose alone. Where the
proportion of noradrenaline to O'-hydroxytryptamine
was greater than one, the response was increased.
In all these instances, the sensitivity of
.
the preparation was greater to 5-hydroxytryptamine
than to adrenaline or noradrenaline. In one case,
the noradrenaline sensitivity was further reduced
by the perfusion of noradrenaline (5,5 x 10" )
itself, along with the ephedrixie. Here, four
times as much noradrenaline as D-hydroxytryptanine
in a combined dose gave a response equivalent to
that elicited by the 5-hydroxytryptamine component
alone. If the noradrenaline was increased to
eight times as much as the 6-bydroxytryptamine the
mixture gave an increased response, (see Discuss¬
ion, p. Ill ).
'
A search was therefore made for a more potent
anti-adrenaline, Dibozane is reported to be ten
times as active as piper-ox&ne, in a test concerned
with adrenaline responses in the isolated rat




sensitivity ratio, adrenal ine/5-hydroxyt ryptamine
in the perfused rabbit ear. However, dibeiizyline
•which was more active than dibozane in the seminal
vesicle test, proved useful. It has a very power¬
ful and long-lasting effect and was therefore given
by injection in small volumes and not by continuous
perfusion. The sensitivity of the ear vessels to
dibenzyline varied from one preparation to another.
The initial dose of dibenzyline was usually 75 pg in
0.5 ml/Page solution, followed by 25 pg doses until
the desired effect was obtained. The full extent
of the antagonism caused by any one dose was reached
almost at once and the sensitivity of the vessels
to noradrenaline and 5-hydroxytryptamine could be
determined in a short time. Larger doses of
dibenzyline eventually led to a decrease in the
sensitivity and in the discrimination of the
preparation towards 5-hydroxytryptamine.
After/
In these later experiments, the sensitivity
ratio noradrenaline/5-hydroxytryptamine is quoted,
for it was appreciated that this was of more value,
(see Table IV), since the extracts were likely to
contain more noradrenaline than adrenaline,

























































































































After It was found that ephedrine, 10"* ,
and dibenzyline (doses varied with the individual
ears), gave the most satisfactory conditions assay
of several samples of dog serum was made.
Routine procedure;
An ear was set up and perfused with
Page solutionj its sensitivity to noradrenaline
and 5-hydroxytryptamine was found, then ephedrine
(10~") was introduced. After redetermining the
sensitivity of the preparation, to show that
5-hydroxytryptamine responses were increased, doses
of dibenzyline were cautiously added until no
improvement of the ratio was found.
The samples were then assayed in terms of
5-hydroxytryptamine. The sensitivity of the
preparation to noradrenaline was checked again at
the end of the assay, it was generally very little
changed (2-4 hours).
Tracings of the preparation of an ear and its
use during an assay are shown, (Fig.7), In this
case, after the dibenzyline (given in one large
dose) the responses of the ear vessels were blocked
for up to 5 ng noradrenaline, 2.5 ng adrenaline,





M. lOng. HT incubated with lOng. Adrenaline and
Mushroom juice
C. Control as M without Mushroom juice
Rat Oestrous uterus 2ml. bath
Effect of incubation with mushroom .juice
at room temperature on the inhibition of
responses to 5-hydroxytryptamine by adrenaline.
Evaluation of crude mushroom .juice
activity.
-
Tests of enzyme activity were
always based on the time taken for a given amount
of mushroom juice to eliminate the inhibitory
effect of a certain amount of adrenaline on the
spasm of rat oestrous uterus caused by 5-hydroxy-
tryptamine.
The portion of rat oestrous uterus was set
up as usual in the 2 ml organ-bath (p«62 ), and
regular contractions were obtained to, say, 10 ng
5~hydroxytryptamine. Then at C, 10 ng of
5-hydroxytryptamine was again given but within the
same dose volume was also 10 ng adrenaline. (Each
dose was left in for 45 seconds and washed out
carefully - 4 minutes interval between doses). The
presence of the adrenaline caused inhibition of the
response and the inhibitory effect gradually dis¬
appeared as the following responses to 10 ng
5-hydroxytryptamine (alone) were recorded. This
gives a measure of the inhibitory effect of a
mixture containing equal quantities of the two drugs
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and the time required for full recovery from
inhibition.
The dose at M contained 10 ng of each drug
as before and 0,25 ml of a 1 in 10 dilution of the
crude mushroom juice per ml (i.e. one fifth of each
dose volume is diluted mushroom juice$ or one
fiftieth is crude mushroom juice.) If this dose is
tested, 1-4 minutes from addition of the mushroom
juice, the inhibition and recovery is very similar
to that for a dose of C. After full recovery of the
10 ng 5-hydroxytryptamine responses, another dose
of M, now 14 minutes from preparation, was given.
This caused a reduced response but did not inhibit
responses to subsequent doses of 5-hydroxytryptamine
At 22 minutes from preparation, M showed no inhibi¬
tory effect.
Thus by standing at room temperature with
adrenaline at pH 4.5-6, the enzyme preparation
was able to abolish in 22 minutes the inhibitory
effect of 10 ng adrenaline on the uterine contract¬
ion caused by 10 ng 5-hydroxytryptaniine. It was
found too that the mushroom juice, in the same dose
as was present in the above mixture, M, had no
effect/
Figure 9
Upper graph shows the results of the experiment
shown in Fig. 8,
Ordinate •» Height of responses to 5-hydroxy-
tryptamin©,
3 - Response to 10 ng 5~hydroxytryptamine.
M - Response to 10 ng 5-hydroxytryptamine
incubated with 10 ng adrenaline and
mushroom juice.
C - Response to control as M, without
mushroom juice.
Lower graph -
s ~ Response to 10 ng 5-hydroxytryptamine.
M - Response to 10 ng 5-hydroxytryptamine
incubated with 60 ng adrenaline and
mushroom juice.
G - Response to control as M , without
mushroom juice.
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effect itself on the 5-hydroxytryptamine response.
Where there was more adrenaline than
5-hydroxytryptamine in a mixture, e.g. 5si, it was
found that the response to the next dose of
6-hydroxytryptamine following the mixed dose, was
smaller than that to the mixed dose. The adrenaline
must take some time to reach its maximum inhibitory
effect on this preparation. It was therefore
convenient, for a number of investigations, to add
the adrenaline, or the adrenaline-mushroom juice
mixture to the organ-bath, one minute before a
5-hydroxytryptamine dose was due in order to give
the adrenaline time to produce its maximum effect.
In experiments carried out in this manner, the
record showed a regular pattern of increasing
responses to 5-hydroxytryptamine as the adrenaline
effect wore off, until responses at the pre-
adrenaline level were again obtained.
Later of course, further tests had to be
made of mixtures of adrenaline and 5-hydroxytrypta¬
mine or of noradrenaline and 5-hydroxytryptamine.
The results of such experiments showed that
the inhibitory action of adrenaline, when present
in/
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in concentrations up to 10 times that of the
5-hydroxytryptamine could always be abolished within
i
40 minutes by treatment of the mixture with mushroom
juice. Under similar conditions, concentrations of
noradrenaline up to 100 times that of the 5-hydroxy¬
tryptamine could be dealt with. 5-hydroxytryptamine
itself proved resistant to the enzyme action for at
least 80 minutes and only a slight decrease in its
spasmogenic activity was noted after 2 hours treat¬
ment with the mushroom juice.
Based on these findings a standard method
was developed, to eliminate interference due to the
presence of adrenaline and/or noradrenaline in the
assay of a tissue extract for its S-hydroxytrypta-
piine content. It comprised the addition of 0.25ml
of a 1 in 10 dilution of the standard preparation of
crude mushroom juice (p. 60) to each ml of the
reconstituted acetone extract residue of the tissue
samples, (or, of these diluted if necessary). Thus
each dose volume of tissue extract placed in the
organ-bath contained one fifth part of diluted
mushroom juice. The mushroom treated sample was
allowed to stand at room temperature and was not
assayed until at least 40 minutes from preparation,
certainly/
Figure 10
Assay of sample of dog serum (acetone
extract)#
Hat oestrous uterus, In 2 ml bath, with
de Jalon's Solution (modified) containing
atropine 10 .
D - l/2 dilution of extract residue
in saline.
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certainly before 2 hours had elapsed. The pH was
tested and found to lie between pH 4.5 and pH 6.
In view of the relatively high concentration
of adrenaline and noradrenaline in the adrenal
glands, the extract residues of these were treated
with twice the standard volume of mushroom juice
for twice the standard time, in an effort to destroy
all the adrenaline and noradrenaline present.
B, Estimates of 5-»hvdroxvtrvnta-
mine in tissues.
Using the acetone extraction method for
the samples of tissues and the mushroom treatment
for removal of the adrenaline inhibitory effect, the
estimates of 5-hydroxytryptamine activity were made
by assay on the isolated atropinised oestrous uterus
of the rat. A few assays were done on the rabbit
ear, and for the dog brain samples parallel assays
were made on the heart of Mactra solida. In most
cases three samples of each tissue, from different
animals, were estimated.
The results are given in the following
tables - /
Figure 11
Assay of sample of rabbit gut mucosa
(acetone extract).
Rat oestrous uterus, in 2 ml bath, with
de Jalon's Solution (modified) containing atropine
_6
10 ,
E - 1/20 dilution of extract residue in
saline containing 0,20 ml diluted
mushroom juice in each ml,
(E) - l/20 dilution of extract residue in
saline without mushroom juice,




Table V - Dog serum 5-hydroxytryptamine
estimates.
Tables V -
Vll Summary of 6-hydroxytryptaiaine
equivalents of various tissues
of the rabbit, (mean estimates).
Table VIII- 5-hydroxytryptamine eqivalents




Dog serum - 5-hydroxytryptamine estimates.
Results - corrected
for recovery.
1. Unanaesthetised dog -
serum - acetone extract - chroma tog rammed 0.48ii.g/ml (0.4-0.6 )
eluates freeze-dried. 0.40p,g/ml (0.3-0,53)
Uterus assay"'- duplicate samples 23-33^
recovery
2. Unanaesthetised dog -
serum - acetone extract _a
Ear assay - (ephedrine 10"" , with
75pg dibenzyline) 0.52iig/ml (0.32-0.84)
50-93%
Uterus assay 0.62{ig/ml (0.46-0,80)
30%
3. Unanaesthetised dog -
serum - acetone extract s
Ear assay - (ephedrine 10"* , with
l50p.g dibenzyline) 0.39jig/ml (0,30-0,59)
7Q%
4. Chloroform anaesthetised dog -
serum - acetone extract
Ear assay - (ephedrine 10" 5 with







Uterus assay = estimation on isolated
oestrous uterus of the rat.
Ear assay = estimation on perfused
isolated ear of the rabbit.
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TABLE VI
Summary of 5-hydroxytryptamine equivalents




















2,0 - 2,5 jig/ml
4.4 pg/ml
These estimations were made on the isolated
oestrous uterus of the rat, and the stimulation
caused by the extract in each case was abolished
by lysergic acid diethylamide, (i.e. L.S.D, +).
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TABLE VII
Summary of 5-hydroxytryptamine equivalents
of various tissues of the rabbit,
(mean estimates)
Brain -
Hypothalamus 0,395 pg/g (+)
Mid-brain 0.370 pg/g C-)
Olfactory bulbs 0.128 pg/g (-)
Cerebellum o•o pg/g (-)
Liver -
with portal perfusion 0,348 pg/g (-)
without portal perfusion 0,943 pg/g (+)
Bone marrow - 0,327 pg/g (+)
Lung - 0.177 pg/g (+)
with direct pulmonary
perfusion 0,136 pg/g (+)
Thyroid 0.164 pg/g (+)
Pancreas 0,116 pg/g (+)
Diaphragm 0,091 pg/g (+)
Salivary glands 0,089 pg/g (+)
Thymus 0.049 pg/g (+)
Heart 0,035 pg/g (-)
Bladder 0,030 pg/g (-)
Kidney 0,025 pg/g (-)
Skeletal muscle <0,018 pg/g
Sciatic nerve <0.067 pg/g
Bile <0,030 pg/g (-)
Adrenal not detectable
Where extraction activity was abolished
by lysergic acid diethylamide estimates are
marked (+), where activity not abolished (-1
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TABLE VIII
5-hydroxytryptamine-equivalent in jxg/g rabbit tissue.
Spleen 13.8 (9,4 - 18.7)
21.0 ( 18 - 26




7.6 ( 6.4 - 9.0)















4.56 ( 3.7 - 6.06:
1.17 (0.93 - 1.56)
0.67 (0.5 - 1.0)
3.5 (2.78- 4.17)
3.74 (2.49-7.48 )
3.97 ( 3.2-6.4 )
0,52 (0.4 - 0.8)
2.98 (2.27 - 3.64)
Blood
I Ether
Siliconed-unclotted Glass-rapid clot Siliconed slow-clo
2. O^g/ml (1.6-2.4)
2.0jig/ml (1.6-2.4)
II Urethane 2.5^g/ml ( 2-3 )
2 • Sji-g/ml ( 2-3 )
2.0|i,g/ml ( 1-2.2)
2.0jxg/ml (1.6-2.4) 2.0jig/ml (1.6-2,4)
2.Opg/ml (1.6-2,4) 2.0iig/ml (1.6-2.4)
2.5yg/ml ( 2-3 )





















Figures in brackets indicate the range of each estimate.
0.137( 0.09-0.28)
0. 028
Where extract activity was not abolished by lysergic acid








0.90 ( 0.72-1.08) 1.45 (1.0 - 2.0)




































































< 0.02 w < 0.05
not detectable because of inhibition of standard
<.-)
Figures in brackets indicate the range of each
estimate.
Where extract activity was not abolished by
lysergic acid diethylamide, estimates are
marked^
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One series of rabbit tissue extracts were
assayed both before and after the standard mushroom
treatment. The increases in the 5-hydroxytrypta~
mine-equivalent are shown in the table below. No
increase in the equivalent was found with serum
which is unlikely to contain significant amounts of
adrenaline or noradrenaline. In this experiment,
none of the extracts gave any response after the
uterus was treated with lysergic acid diethylamide,
so the increase is probably due to an unmasking of
more 6-hydroxytryptamine activity.
TABLE IX








Kidney 0.020 0.026 1.25
Lung 0.060 0.075 1.25
Pancreas 0.147 0.213 1.45
Liver 0.660 0,900 1.80
Serum 4.400 4.400 1. 00
Parallel/
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Parallel assays - Dog brain samples.
Extracts of certain areas of dog brain were
prepared with acetone (see p.46 ). The following
day, the dry residues were taken up in 1 ml
distilled water and diluted with saline if necessary.
This solution was assayed directly on the Mactra
heart, while an aliquot was treated with standard
crude mushroom juice and assayed on the isolated
rat uterus in oestrus.
TABLE X
Acetone extracts of dog's brain,
6-HT-equivalent ng/g.
Hat uterus Mactra heart RATIO
Olfactory 40 62 0.65
bulbs 33 31 1.06
43 25 1.72
Cortex of 0{< 12) 12 < 1.0
carebellum 0(< 20) 7 < 2.85
0( < 30) 8 <3.75
Sympathetic 260 0(^C 59) 4.4
ganglia 162 0( < 19) >8.5
240 0( < 29) >8.3
Caudate 45 88 0.51
nucleus 117 200 0.58
Hypothalamus 1010 555 1.82
415 280 1.48
930 224 4.15
1 ng - 10"3 jig -
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TABLE XI
Acetone extracts of dog hypothalamus and




Rat uterus 770 130
Guinea-pig ileum <400 <60
Substance P equivalent
imlts/&.
Rat uterus 216 1.38
Guinea-pig ileum <36.9 <0.20
TABLE XII











Chromatography- including the use of
IRC 50 and freeze-drying.
In the chromatography experiments which
! - " •
set but to find a separation of the position reached
by adrenaline from that reached by S-hydroxytrypta-
mine, only one method, the ascending method on paper,
was used. This limited, necessarily the time for
development, for once the solvent had reached the
top of the sheet of paper there was no further
increase in the distance travelled by the amines.
If there is a real, though slight difference in the
■
rate of progress of adrenaline from that of
.... .. - • • •
.
5-hydroxytryptamine, it might have been better
exploited by a descending method, where the
development time can be so much increased.
Pure solutions of 6-hydroxytryptamine are
rather unstable to heat and to evaporation under
reduced pressure at 37°C. If such solutions are
acid or alkaline (pH <4 or >8) the loss of
5-hydroxytryptamine activity on evaporation is
almost complete. Similar losses were noted by
There/
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There is however, a fairly satisfactory
recovery of 5-hydroxytryptamine added to acetone
extracts of tissues, or in the presence of adequate
buffering at pH 6-7. Yet when the solution of
5-hydroxytryptamine had had previous contact with
chromatography paper (Whatman No.1, washed with
0,01 N hydrochloric acid) it was again less stable
to evaporation despite buffering at pH 6-7.
Something seemed to come out of the paper and either
aid in the oxidative destruction of 5-hydroxytrypta-
mine or complex with this in such a way that its
ability to stimulate the isolated oestrous uterus
was impaired. For, all the assays of the samples
were made on the isolated oestrous uterus of the
rat. Yet, how something could still be present on
the paper, and coming off in sufficient quantity to
have such an effect on the 5-hydroxytryptamine is
strange - after the paper was washed even for 48
hours with 0.01 N hydrochloric acid, or washed with
0.01 N sodium hydroxide and then 0,01 N hydro¬
chloric acid. In similar work, Fingl (1953) was
unable to make quantitative recovery of small
amounts ( < 2pg) of 5-hydroxytryptamine.
The/
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The results from the concentration of
solutions of s-hydroxytryptamine by passage through
the IRC 50 resin columns are puzzling. On some
occasions, recoveries were high and on others, low -
and even inhere the columns were being treated
strictly in parallel the result from one might be
high and from another, low. Fingl (1053) did some
work on this problem also, but he was not concerned
to remove the adsorbed 5-hydroxytryptamine in a very
small volume. He was interested in the separation
of 5-hydroxytryptamine from histamine and acetyl-
histamine, and he did show quantitative recovery of
10 p,g samples of 5-hydroxytryptamine at pH 6.9.
The columns used here, were however, smaller.
The concentration of phosphate, as buffer, in the
percolate, made the testing of whether all the
5-hydroxytryptaaine had in fact been adsorbed,
rather difficult. The response of the isolated
uterus is inhibited by phosphate.Where tests were
made it was found that a good part at least of the
5-hydroxytryptamine was taken up. But the elution
from the columns was not quantitative.
Then, when freeze-drylng was used for the
concentration of the samples it was found just how
important/
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important is the control of pH during drying.
Phosphate buffer was the most satisfactory at the
required pH (i.e. pH 6,5). Yet the sensitivity
of the uterus to inhibition by phosphate prevented
the excessive use of this buffer} the isolated rat
oestrous uterus preparation was used for all assays
at this time. In a few cases, where the uterus
was particularly sensitive to the phosphate, a
similar concentration of phosphate was added to the
standard 5-hydroxytryptamine solution and the
buffered freeze-dried samples compared with this.
The recovery of 5-hydroxytryptamine from chromato-
grams, the eluates of which were freeze-dried, was
50^ whereas the recovery of 5-hydroxytryptamine
added to serum and similarly treated was only 23-
33/. This loss remains unexplained.
Isolated perfused ear of the rabbit
The experiments with the perfusion of
ephedrine through the vessels of the rabbit ear,
gave the expected changes in sensitivity to adrena¬
line and 5-hydroxytryptamine responses. Low
3
concentrations of ephedrine (10" ) caused an increase
in the responses to both drugs} higher concen-
3
trations (1CT ) caused some inhibition of adrenaline
responses/
109
responses with further sensitisation of the ear
4
vessels to 5-hydroxytryptamine; ephedrine (10" )
blocked responses to both drugs. These changes
are discussed by Gaddum and Kwiatkovski (1938) and
by Gaddura and Haineed (1954) on the following theory.
Ephedrine causes inhibition of amine oxidase, there¬
fore, since this enzyme destroys both drugs, it
potentiates the response to both adrenaline and
s
5-hydroxytryptamine. But at a concentration of 10 ,
ephedrine tends to block the adrenaline receptors,
though still higher concentrations are required
before it will block the tryptamine receptors.
Ephedrine 10 proved to be the optimum
concentration for partial blockade of adrenaline
responses, and stimulation of 6-hydroxytryptamine
responses; thus giving a high equivactive dose-
ratio adrenaline/6-hydroxytryptamine. This ratio
was not improved by the addition of a fairly specific
anti-adrenaline drug, e.g. piperoxane, (Gaddum and
Hameed, 1S54) or regitine, and in fact, the
sensitivity of the ear vessels to 5-hydroxytryptamine
was much more reduced than that to adrenaline so
that the ratio became less. Was there a displace¬
ment of the ephedrine from the adrenaline receptors
by the piperoxane, so that the ephedrine was now
free/
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free to block the tryptamine receptors? Or, was
the piperoxane concentration effect simply additive
the molecules filling available receptors of either
kind?
5
In the presence of ephedrine 10~ , a dose
containing equal quantities of adrenaline and
6-hydroxytryptamine causes a vaso-constriction
equal to that caused by the 5-hydroxytryptamine
component alone. Where the combined dose contained
more adrenaline, the response was increased despite
the fact that the adrenaline component alone was
considerably inhibited by the ephedrine. Similar
effects were recorded with noradrenaline and
5-hydroxytryptaaine given together, during
ephedrine perfusion, even when the noradrenaline
dose, alone, gave a threshold vaso-constriction or
sometimes even a \rasodilatation.
_ l o
Also, while noradrenaline (2,5 x 10" ) was
perfused along with ephedrine, noradrenaline
responses were further inhibited and when four times
as much noradrenaline as 5-hydroxytryptamine were
given together, the response was not increased over
that to 5-hydroxytryptaaine alone. But where more
noradrenaline was added to the 5-hydroxytryptamine
dose/
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dose, the response was again increased.
This increased response effect was important
because though a test with adrenaline or nor¬
adrenaline alone would give no response and the ear
be considered insensitive to these drugs, yet the
presence of either or both of these in the tissue
extract, would have an influence on the 5-hydroxy-
tryptamine estimate.
So more powerful adrenolytic drugs were
tested. Dibenzyline was found satisfactory as an
inhibitor of adrenaline vasoconstriction, though the
dose required in the various ear preparations varied
The required effect had to be built up with added
doses. Unfortunately, dibenzyline, in the presence
of ephedrine,was not entirely specific. In a few
cases, together they further inhibited the noradren¬
aline response and also flattened the S-hydroxy-
tryptamine dose-response curve. In other cases,
dibensyline caused marked inhibition of the
6-hydroxytryptamine responses, as the ephedrine and
piperoxane together had done.
This preparation was considered unsuitable
for routine assays, because of the time which it took
to prepare and the poor discrimination between doses




The enzymes in crude mushroom juice
were very suitable for the destruction of adrenaline
activity, in mixtures of adrenaline and 5-hydroxy-
tryptamine. The preparation was easy to use, since
it is active at pH 4-6, which was the reaction of
the extracts, and since it is active at room temper¬
ature.
The activity of the juice is not purely poly-
phenoloxldasej it has a monophenoloxidase property.
Fortunately for our purpose the lag time before the
monophenoloxidase reached its maximum activity was
such that the concentrations of adrenaline used were
oxidised by the polyoxidase before the mono-oxidase
attacked the 5-hydroxytryptamine. By measurement of
oxygen uptake and loss of biological activity,
Philpot (1940) showed a conversion of over 95% of
adrenaline to adrenochrome by a preparation of 20^
pure polyphenol oxidase from mushrooms.
Erspamer and Boretti (1951) sprayed chroraato-
grams with diluted mushroom juice and showed a
coloration of spots identified as enteramine
(5-hydroxytryptamine), octopamine (p-hydroxyphenyl-
ethanol amine), tyrosine and tyraiaine. These
reactions were probably due to the monophenoloxidase,
giving oxidation products which polymerised to form
coloured compounds.
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B. Dos serum - fr-hydroxytryptamine estimates.
The mean serum 5-HT-equivalent for
a normal dog was 0.48 p.g/ml. This estimate
includes five values obtained from serum of the
same dog, some as duplicate determinations and all
on samples of blood taken within a three month
period. They range from 0,39 jxg/ml - 0.62 pg/ml.
(A single estimate was made in blood from a dog
under chloroform anaesthesia. This value was
0.30 pg 5-hydroxytryptamine per ml serum).
All the assays were made on extracts which
had been prepared from the serum with 20 volumes
of acetone. The acetone was removed under reduced
pressure and lipids extracted from the aqueous
residue with petroleum ether. The resulting
extract was subjected in one case to paper chromato¬
graphy.
Each estimate was governed by a recovery
determination, i.e. pure 5-hydroxytryptamine was
added to a corresponding sample of serum and
extraction completed. For the acetone extraction,
the recovery is 50 - 95^. In the chromatography
experiment the recovery was 23 - 33%.
Because/
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Because these estimates were made on a single
dog they cannot be compared with the mean figure
obtained by Erspamer and Faustini (1953) for normal
dogs, i.e. 0.21 p.g 5-hydroxytryptamine per ml serum.
However, the mean estimate obtained in the present
work lies within the range of their figures which
was 0.08 |i.g/ml - 0.57 pg/ml and covered ten estimates.
Erspamer»s extraction method was more prolonged and
employed a lower concentration of acetone than that
used here. The blood was allowed to stand at room
temperature for 3*5 hours and then for 16-20
hours in the refrigerator, until the clot was con¬
tracted and the serum had separatedj whereas, here,
the blood was not standing at room temperature for
more than 20 minutes before the serum was separated
by centrifugation. Then Erspamer and Faustini used
just four volumes of acetone, a concentration of 80$,
whereas here a concentration of 95$ was used.
Twarog and Page (1953) made similar acetone
extracts of serum to those of Erspamer and their
estimates for two samples of dog serum were 0.12 pg
5-hydroxytryptamine/ml and 0,2 - 0.3 jig/ml.
A higher 5-HT-equivalent for dog blood was
found by Udenfriend and Weissbach (1954). They
made a butanol extract of the platelets only and
estimated/
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estimated the 5-hydroxytryptamine in it by a
fluorescence method. Their value is 0.25 p.g
5-hydroxytryptamine/ml whole blood.
5-hydroxvtryptamine content of rabbit
tissues.
The 5-HT-equivalent for rabbit
blood is high, compared with that of other animals,
(Erspamer and Faustini, 1953; Erspamer, 1954a or b),
thus the blood had to be removed as far as possible
from the tissues before sampling. This was done
with an isotonic saline and was complete in about
15-20 minutes. It may also have washed some
5-hydroxytryptamine out of the tissues themselves,
though perhaps this is not of any real significance
except in a loosely packed tissue containing a high
5-HT-equivalent, e.g. spleen. Another danger,
possibly incurred by this perfusion treatment is
that of causing oedema of the tissues in which case
the 5-HT-equivalent, determined per gram of sample
would be low. There was no evidence of oedema, to
the naked eye inspection, except in one case of
thyroid and submaxillary glands which were rejected.




When the perfusate was almost colourless,
it contained probably less than 1% of blood. Thus
if a 2 gm sample of tissue were to contain 1 ml of
this saline perfusate, the "blood-5-hydroxytryptamine"
content of this sample would not be more than 0.025
H-gs (rabbit blood contains 2.5 p.g 5-hydroxytrypta-
mine/ml). Thus tissue 5-HT-equivalents were
considered to be quite significant when they were
more then 0.100 jxg/g.
The estimate of 5-hydroxytryptamine in rabbit
blood was 2,0 - 2.5 pg/ml whole blood and 4.4 jig/ml
serum, from acetone extracts in each case. The
5-HT-equivalent for rabbit serum given by Erspamer
and Faustlni (1953) is 3.53 p.g/ml. Another
result is given by Erspamer and Sala (1954): it is
4.3 ^g/ml serum from ten samples. (No explanation
is given of this difference! Udenfriend and Weiss-
bach (1954) quote a value of 4.0 ^g/ml of whole
blood, which is high compared with these other
estimates. Their method is a chemical one, involving
the fluorimetric estimation of 5-hydroxytryptainine
in an extract of the platelets.
From the work of Held and Rand (1951) and
Zucker (1951) it seems quite clearly indicated that
5-hydroxytryptamine occurred within the platelets
and/
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and was only released into the blood with their
normal breakdown in the body or with clotting.
The metabolic studies of Udenfriend and Weissbach
(1964) using C14 labelled tryptophan, confirmed this
view. These authors suggested that 5-hydroxy-
tryptamine synthesis occurs at the site of platelet
formation, and, having been incorporated in the
platelets remains inert within them until they are
ruptured and disintegrate. Yet, Humphrey and Toh
(1954) showed that the platelets were able to
adsorb 5-hydroxytryptamine against a concentration
gradient, from the medium in which they were
suspended.
Two experiments here showed that there was
no synthesis of 5-hydroxytryptamine during in vitro
clotting, (p. 51 • ). The estimate of 5-hydroxy-
tryptamine per ml whole blood was the same, whether
the blood was prevented from clotting by being
passed immediately from siliconed vessels into
acetone, or was allowed to clot either rapidly or
slowly.
Free-flowing rabbit blood was collected
through a polythene cannula into a siliconed tube.
One ml samples were measured with a siliconed
pipette,/
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pipette, directly into 20 ml acetone (duplicates A
and B), into dry sillconed glass flasks (C and D),
and into dry non-siliconed glass flasks (E and F),
Extraction of the samples A and B was proceeded with
at once, while C, D, E and F were left to clot at
room temperature. For some time the samples C and
D were quite fluid but after 5 hours they had
clotted, whereas E and F clotted within a few
minutes of pipetting. These samples were then
extracted. Assay of the extracts was made on the
atropinised oestrous uterus of the rat and for each
sample the 5-HT-equivalent was within the range 1,6-
2,4 pg/ml serum.
In the second experiment, one ml samples of
blood were measured and some placed directly into
20 ml acetone while others were placed in dry flasks
and left to clot. Extraction of the samples in
acetone was proceeded with at once, and after one
hour the clotted samples were similarly extracted.
The 5-HT-equivalents were again in good agreement,
(see Table VIII).
A high 6-HT-equivalent was found in the
spleen, though the mean figure was lower than that
found by Erspamer (see Table XIII). This discrepancy
is/
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is possibly due to the blood content of the spleens sampled by Erspamer
(1954a and b). The contraction of the spleens caused by electrical
stimulation and leading to expulsion of perfusion fluid from the sinuses,
gave no difference in their 5-hydroxytryptaiaine content per gram,
TABLE XIII
Comparison of 5-hydraxytryptamine content of rabbit spleen and mucosae,
Erspamer«s estimates
(Erspamer 1954a &- b)





















The values for 5-hydroxytryptamine in the mucosae of the various
areas of the intestinal tract correspond to those of Erspamer (1954a & b).
However, his estimates show a decreasing concentration (excluding the
pylorus mucosa) from the stomach fundus to the colon, whereas the figures
found in the present study represent a high 5-hydroxytryptamine
concentration in both the stomach and large intestine/
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intestine mucosae, with lesser concentrations in
the small intestine mucosa.
Using the atropinised rat colon for assays,
Feldberg and Toh (1953) obtained higher 5-FT-equiva¬
lents for acetone extracts of rabbit gastric mucosa,
viz. Fundus mucosa 7.5 - 10 pg 5-hydroxytryptamine
per gram and pylorus mucosa 1,25 pg £-hydroxytrypta-
mine per gram,
let the relatively high 5-hydroxytryptaaine
content throughout these mucosae samples is
consistent with their high content of entero-
chromaffin (argentaffin) cells.
The bone marrow had a fairly consistent,
significant content of 5-hydroxytryptamine but it
would be difficult to say whether this was due
entirely to that in the platelets of the blood
circulating through the vascular sinuses, or whether
part of it was due to 5-hydroxytryptamine in the
megakaryocytes (already synthesized for the time
when these break down to form platelets).
When the liver was perfused with saline via
the portal vein as well as via the aorta, the 5-HT-
equlvalent of the samples was lower than it was if
only aortic perfusion was made. The most likely
reason for this difference is that in the second
case/
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case blood was still trapped in the portal sinuses.
A voluiae of 0,25 ml blood per g in the tissue would
contribute 0,5 pg 5-hydroxytryptamine per g tissue.
This proportion, 1 in 4, of portal blood to tissue
is perhaps rather high, but it may be that though
less blood is present, excess of platelets are
trapped prior to their destruction by the liver
cells, and that these platelets as well as the blood
be washed out by the saline perfusion.
The 5-KT-equivalents for the samples of lung
tissue varied rather widely. The lungs contain
amine-oxidase which destroys 5-hydroxytryptamine and
some workers believe that megakaryocytes from which
platelets are formed occur there, also. Should
■
these cells contain 5-hydroxytryptamine it may be
that the differing balance between these activities
I
of production and destruction caused the various
estimates.
Other tissues which contained small but
significant amounts of 5-hydroxytryptamine, more than
0.1 p.g/g, were the thyroid and the pancreas. It is
interesting to note that Erspamer (1937) described
' •' • •
enterochromaffin cells in the pancreas of certain
mammals, including the hare. The pancreas of the
rabbit/
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rabbit was not examined by him.
All these 5-HT-equivalents were found from
assay of mushroom treated acetone extracts of the
tissues on the atropinised oestrous uterus of the
rat. On this preparation, the spasm caused by
5-hydroxytryptamine is specifically blocked by
'
lysergic acid diethylamide, After each assay,
sufficient lysergic acid diethylamide was added to
the organ-bath to abolish the standard response to
5*hydroxytryptasine. In the case of all the tissues
mentioned above, blood and serum, spleen, mucosae,
bone marrow, liver, lung, thyroid and pancreas,
except the *portal perfused' liver, the extract
activity was abolished by lysergic acid diethyl¬
amide. Thus in these extracts, at least a very large
proportion of the response was probably due to
5~hydroxytryptamine. The tests of the liver samples,
positive when the 5-HI-equivalent was high and
negative when it was low, suggested the presence of
some less active substance in the extracts.
In the extracts of each of the other tissues
sampled the activity was neither consistently
abolished by lysergic acid diethylamide nor \v7as it
consistently resistant to this antagonist. The




more than 0,1 p,g 5~hydroxytryptaEiine per gram. It
may be said that there was a trace of 6-hydroxy~
tryptamine in the diaphragm, salivary glands and
thymus, but in the heart, bladder, kidney, skeletal
muscle, sciatic nerve, and bile, no definite evidence
for the presence of any 5-hydroxytryptamine was
obtained.
No uterus stimulating activity was recorded
from the adrenal extracts, but only an inhibitory
effect on .subsequent 5-hydroxytryptamine doses.
This observation results presumably from an incom¬
plete destruction of the adrenaline content of these
glands, even with twice the usual amount of mushroom
juice and twice the standard incubation time. The
extracts became faintly red in colour probably owing
to the relatively high concentration of adrenochrorae.
Parallel assays of dog brain samples.
The S-HT-equivalents for the
olfactory bulbs and for the cerebellar cortex from
assay on the rat oestrous uterus and on the heart of
Mactra solida agreed fairly well. There was a small
amount of activity in the olfactory bulbs, (mean of
estimates on rat oestrous uterus = 38.7 ng/g., and
on/
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Blockade of 5-hydroxytryptamine responses
by lysergic acid diethylamide.
At L.S.D, 2 fcig of lysergic acid diethyl¬
amide were in contact with the uterus for 10
minutes.
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on Mactra heart = 39.3 mg/g) and the activity in
the cerebellar cortex was negligible. The other
results suggest either varying proportions of
6-hydroxytryptamine and some other principle in the
areas sampled, or 6-hydroxytryptamine plus another
•
principle peculiar to each area. These samples
were all treated with mushroom juice before assay
on the rat oestrous uterus, but they had not been
treated with mushroom juice when assayed on the
Mactra heart. (This latter preparation is very
insensitive to stimulation by adrenaline). The
estimates made on the rat oestrous uterus were
higher than those found by Amin, Crawford and
Gaddum (1964) for similar extracts untreated with
mushroom juice.
After treatment of the rat uterus preparation
with the specific 6-hydroxytryptamine antagonist,
lysergic acid diethylamide, the mushroom treated
samples of sympathetic ganglia, hypothalamus and
...
caudate nucleus caused responses, whereas Amin et
al (1964) had found that the response to similar
samples not treated with mushroom had been abolished.
No specific antagonist for 6-hydroxytryptamine
* |—
stimulation in the Mactra heart has yet been found,
so/
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so it is not possible to say whether the stimulation
of it caused by the acetone extracts was indeed due
entirely to 5-hydroxytryptamine.
Though it was thought unlikely that the
samples might contain substance P, parallel assays
were made of mushroom treated extracts on the rat
oestrous uterus and guinea-pig ileum preparations.
From this experiment (p. 104, Table XI), the active
principle, other than 5-hydroxytryptaiaine is shown
not to be substance P which, though present in the
tissues, is as designed in the method of
extraction left in the insoluble residue during
the treatment with 20 volumes of acetone.
A parallel assay of one sample of dog hypo¬
thalamus was made on the isolated oestrous uterus
of the rat, and on the perfused ear of the rabbit.
The extract was prepared as usual with acetone and
the lipids were removed, but it was not subjected
to mushroom juice treatment. The estimates were in
agreement but were much higher than was usual for




It might be inferred from the results of
j
the parallel assays on the rat uterus and Mactra
heart preparations that a new pharmacologically
active principle had been discovered. However, in
view of the small number of experiments done and
the possibility of there being an artefact caused
by this particular mushroom juice preparation, that
l
conclusion cannot yet be drawn.
SUMMARY
Recently Arnin, Crawford and Gaddum (1954a
and b) developed a method for the extraction and
estimation of 5-hydroxytryptamine in samples of
brain tissue, which depended for assay on responses
evoked in the isolated oestrous uterus of the rat.
This preparation is sensitive to inhibition by
adrenaline and it may be that there was sufficient
adrenaline in certain of the extracts to make the
5-hydroxytryptamine estimate too low. This study
.
aimed to eliminate the adrenaline interference in
estimation of various tissues for 5-hydroxytrypta-
.
mine.
An attempt was made to separate 5-hydroxy-
_ '
tryptamine from adrenaline by paper chromatography,
elute/
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elute the 5-hydroxytryptamine from the appropriate
strip, and estimate the activity - now free from
any adrenaline - on the oestrous uterus of the rat.
However, a solvent giving more than a small Rp
difference was not found among those tested. In
addition, it was found that in the eluates from
chromatography paper 5-hydroxytryptamine was rather
unstable, particularly during the evaporation
necessary for the concentration of eluates "before
estimation. If careful control of pH was made at
pH 6-7, eluate activities could be stabilised during
freeze-drying and samples were thus prepared for
estimation - always in parallel with 'recovery*
samples to which standard 5-hydroxytryptamine had
been added before chromatography.
As a result of this failure with physical
methods of separating 5-hydroxytryptamine from





For a time, the assay method was changed to
calibration of vasoconstriction in the isolated ear
of the rabbit. This is a sensitive preparation to
5-hydroxytryptamine, under certain conditions,
provided/
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provided the vasoconstrictor effects of adrenaline
and noradrenaline can be minimised. This was done
by the use of ephedrine and dibenzyline together.
The treated preparation was fairly satisfactory,
and was used on a number of occasions, but the
dibenzyline tended to lower its discrimination to
varied doses of 6-hydroxytryptamine.
It was found that by the activity of the
polyphenoloxidase enzyme present in mushroom juice,
the inhibitory effect of adrenaline on the rat
uterus could be eliminated. It thus became possible
to return to the more regular and sensitive rat
oestrous uterus preparation for assays. All the
tissue extracts were treated with a standard
preparation of crude mushroom juice previous to
5-hydroxytryptamine estimation.
A survey of the 5-hydroxytryptamine content
of acetone extracts of rabbit tissues was made.
Since rabbit blood has a relatively high 6-hydroxy-
tryptamine equivalent, efforts were made to wash the




Significant amounts of 5-hydroxytryptamine
were found in the spleen (11.7 pg/g) j various areas
of gut imicosa (1.6-6.15 p.g/g)» blood(2.0-2,5 jig/ml)
and serum (4.4p,g/ml) as previously determined by
Erspamer (1954a and b). The hypothalamus, the
liver and the bone marrow showed smaller (0,3-0.9
H-g/g) but still significant amounts of 5-hydroxy-
tryptamine. In the liver, possibly part of the
estimate is due to 5-hydroxytryptamine from the
blood content of the tissue at the time of extractic
marrow, too, contains circulating blood which it
would be almost impossible to wash out.
Other tissues contained little S-hydroxy-
tryptamine (0.05-0.2 jig/g) , for example, lung,
thyroid, pancreas and diaphragm} while in yet other
5-hydroxytryptaraine was not detectable, skeletal
muscle, bile and adrenals ( <-0.03 y-g/g).
The only test of specificity of the extract
activity was by its influence on the lysergic acid
diethylamide treated uterus. Lysergic acid
diethylamide is a specific antagonist of 5-hydroxy¬






The test was positive (i.e. lysergic acid
diethylamide abolished the extract response) for
extracts of spleen, gut mucosa, blood, serum, bone
marrow, hypothalamus, lung, thyroid, pancreas,
diaphragm, salivary glands and thymus. It was
negative for midbrain, olfactory bulbs, cerebellum,
and the tissues containing the equivalent of less
than 0.04 jig 5-hydroxytryptamine per gram.
The 5-hydroxytryptamine equivalent of the
serum of a dog was estimated by various methods
including paper chromatography with freeze-drying
of the eluates, and parallel assays on the rat
uterus and rabbit ear preparations. Estimates
ranged between 0.39 |ig and 0.62 pg. 5-hydroxy¬
tryptamine with the mean at 0,48 pg/ml serum.
Certain areas of dog brain and dog sympathetic
ganglia were extracted with acetone, and the extracts
estimated directly on the Mactra heart, while
aliquots were treated with mushroom juice and esti¬
mated on the isolated oestrous uterus of the rat.
The assay results for the sympathetic ganglia, the
hypothalamus and the caudate nucleus did not agree
and the discrepancies suggested that the extracts
contained some pharmacologically active principle
other/
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other than 6-hydroxytryptamlne. It was shown too
that these particular extracts were still stimu¬
latory to the uterus after 5-hydroxytryptamine
responses had been abolished by lysergic acid
diethylamide. However, sufficient experiments
have not been done for there to be confidence that
another pharmacologically active principle is here
revealed, and not just some artefact arising




on the Isolated guinea-pig ileum.
These studies on the effects of
antagonists on the responses induced by 5-hydroxy-
tryptamine in the isolated guinea-pig ileum, were
undertaken as an investigation of the possible role
of 5-hydroxytryptamine in the animal body.
5-hydroxytryptamine itself, or a compound very
closely related to it,is present in a wide variety
of animal tissues. Also, the recent work of
Udenfriend and Weissbach (1954), and of Erspamer,
(1955) on the metabolism of 5-hydroxytryptamine
showed that the whole body content of this substance
was completely replaced in 2 - 5 days, Erspamer,
(1954) believes that the 5-hydroxytryptamine is
synthesised by the enterochromaffin cells, that it
is a hormone concerned with the control of diuresis,
and that its presence in the platelets is merely as
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a convenient mode of transport. He emphasises the
•physiological' nature of the action of 5-hydroxy-
tryptamine on renal haemodynamics and function.
Udenfriend and Weissbach (1954), however, believe
that 5-hydroxytryptamine is incorporated in the
platelets at the site of their formation, and though
inert within them is liberated wherever platelets
are destroyed.
The presence of 5-hydroxytryptamine in
nervous tissue (Amin, Crawford and Gadduia, 1954)
and its various spasmogenic, vasoconstrictive and
cardiac activities, suggest that it may have some
other function in the control of the normal working
of the animal body. Thus these studies were done
with certain antagonists in a search for effects
peculiar to 5-hydroxytryptamine-induced spasm of the
isolated guinea-pig ileum. This is a smooth muscle
organ containing a plexus of parasympathetic
ganglion cells.
Certain antagonists were given for a short
period only - 1-10 minutes - and their immediate
inhibitory effect on 5-hydroxytryptamine and a
•control' drug, either nicotine, acetylcholine or
histamine, was recorded. The recovery of the
responses/
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responses from the inhibition was also recorded.
A quantitative study of atropine and certain
atropine-like compounds was made. The pAio
index was used as a measure of inhibitory effect on
spasm of the isolated guinea-pig ileum. This
index was determined by the method of Schild and is
defined as the negative logarithm of the molar
concentration of the antagonist in the presence of
'
which a 10-fold dose of spasmogenic drug causes a
response equal to that elicited by a single dose of
the drug, in the absence of the antagonist (Schild,
1947).
A. Experimental Method. Isolated
guinea-pig ileum.
Small guinea-pigs ( ~150 g) were fasted over¬
night and killed by a blow on the head. Portions
of the ileum (1.5 - 2 cm long) were taken from
nearest to the caecum and were suspended in Tyrode
solution at 36 - 37°C. These were found to be
sensitive to 6 - 40 ng, 5-hydroxytryptamine ( 2 ml
bath), and showed satisfactory, steady responses,
which were recorded with a light frontal writing




Some antagonists were tested for their
immediate short-term effects on 6-hydroxytryptamine
responses of the ileum, compared with their effects
on acetylcholine, nicotine or histamine responses.
Once steady responses were obtained to a suitable
dose of 6-hydroxytryptamlne and one (or more) of
the control drugs, an antagonist dose was given
immediately after a drug dose had been washed out.
It was left in either a) until the next drug dose
had been given and both drug and antagonist were
washed out together, (e.g. cocaine and 6-amino-
tetrahydrocarbazole) or, b) for 2-10 minutes after
which it was removed and the dosage regimen resumed
in the presence of Tyrode solution, (e.g. dihydro-
j
ergotamine). Yohimbine itself caused a con¬
traction and was washed out after 60 - 90 seconds
contact with the tissue.
By adding the antagonist dose on one
occasion immediately before a 6-hydroxytryptamine
dose, and after full recovery of the responses,
repeating that antagonist dose before a control
dose, the pattern of inhibition and recovery of
























clearly seen. The antagonist dose was then
increased and the experiment repeated.
The effect of a large dose of 5-hydroxy-
tryptamine and of nicotine was also investigated,
In these experiments the 'antagonist' was given
either as one large dose or by continuous perfusion.
The antagonistic drugs studied, and
their effects as recorded here.
Cocaine.
On the isolated guinea-pig
ileum, cocaine causes a reversible inhibition of the
spasm induced by 5-hydroxytryptaiaine, without having
much effect on histamine or acetylcholine responses,
(Sinha and West, 1953? Robertson, 1953? Rocha e
Silva, Valli and Picarelli, 1953? G&ddum and Hameed
1954). This was explained by the various workers
on the theory that 3-hydroxytryptaraine acts through
the nerves of the intestinal preparation and that
cocaine prevents its action by paralysing these
nerves.
In the present work, low doses of cocaine
were/
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were shown to potentiate the 5-hydroxytryptamine
induced contractions of the isolated guinea-pig
5
ileum. In higher doses (5 x 10" ), cocaine caused
some slight inhibition of the responses, while with
_4
a cocaine concentration of 10 , the effects of both
5-hydroxytryptamine and nicotine were reduced to a
similar extent, but the responses to histamine were
unaffected.
Yohimbine.
The responses of the isolated rat
uterus to 5-hydroxytryptamine and to tryptamine were
depressed by yohimbine (5 x 10 ).. This antagon¬
ism was not very specific for the response to
acetylcholine was also depressed, though to a lesser
degree (Gaddum and Hameed, 1954). Erspamer (1952)
6
reported that yohimbine ;2 x 10" ) caused very
little change in the response of the rat uterus to
5-hydroxytryptamine.
The antagonistic action of yohimbine on
5-hydroxytryptamine stimulation of isolated strips
of carotid artery is marked, reversible ana sur¬
mountable, (Reid and Rand, 1952). No indication
is given of the specificity of this action.
Page/
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Page and McCubbin (1953b) recorded a
reversal of the 5-hydroxytryptamine pressor action
in dogs. This was particularly well displayed when
the pressor effect had been potentiated by a
ganglionbLockade caused by hexamethoniura.
The guinea-pig ileum is stimulated directly
by yohimbine. In the experiments reported here,
when the contraction was complete and relaxation had
begun, the yohimbine was washed out of the organ-
bath (60 - 90 seconds contact). The maximum
inhibitory effect of a dose of yohimbine, on other
responses in the ileum occurred about 12 minutes
'
from the beginning of the yohimbine contraction.
This inhibition was possibly slightly more effective
against nicotine or acetylcholine. Yohimbine was
6
_ 5
tested in concentrations of 10 and 10
6-amino 1:2 :3 i4~tetrahydrocarbazole.
In 1953, the studies of Woolley and
Shaw on antimetabolites of 5-hydroxytryptamine,
included the investigation of the action of 6 amino-
tetrahydroearbazole. It was among the
more active members of a series of structural inter¬
mediates between 6-hydroxytryptamine and yohimbine.
It/
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It prevented the 6~hydroxytryptaraine induced
contraction in a concentration similar to that
required for 2t3 dimethyl SJamino indole. The
inhibitory effect was surmounted by higher doses
of 5-hydroxytryptamine. (Woolley and Shaw, 1963f
Shaw and Woolley, 1963).
On the isolated oestrous uterus of the rat,
6-amino tetrahydrocarbazole exerted a feeble,
though specific, antagonistic effect on spasm caused
by 6-hydroxytryptamine. This antagonist reached
its maximum effect in 10 minutes and its inhibitory
action could easily be removed by washing, (Hameed,
1964). It was noted that the «6' position in the
carbazole compound corresponds to the '6' position
in the tryptamines.
A sample of 6-amlno tetrahydrocarba&ole was
supplied through the courtesy of Glaxo Laboratories
It was reported by Mr. Tomish, working at Glaxo, to
be more active in the inhibition of 6-hydroxy-
tryptamine-induced spasm, than of acetylcholine
spasm in the isolated guinea-pig ileum.
This effect was shown here but the dis¬
crimination of the antagonist between the two drugs
seems/
Urn* Ai
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Guinea-pig ileum in Tyrode at 37 °C. 2 ml bath
HT - Response to 20 ng hydroxytryptamine.
N - Response to 1000 ng nicotine.
Dose interval - 3 minutes.
40 (ig C - 40 p,g 6-amino tetrahydrocarbazole
added at 1 and washed*out at 1.
140
seems very small. Also, the activity of 6-amino-
tetrahydrocarbazole was only one tenth that reported
by Tomish, Matching responses to nicotine and
5-hydroxytryptamine were similarly reduced by this
8




Benzimidazole was first studied pharma¬
cologically by Goodman, Oilman and Hart (1943), who
showed that it produced a reversible flaccid
paralysis. This effect was obtained orally and by
Injection and was evident in decreased nniscle tone,
decreased voluntary movement and a loss of postural
reflexes. There was no alteration in the spontaneous
electrical activity of the cortex so the conclusion
of these workers was that benzimidazole has a highly
selective/
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selective depressant action on the cerebro-spinal
axis. Other experimentors showed that this
paralysis was not due to a curare-like action but
to a selective depressive effect on spinal inter-
neurones. (Domino, Unna and Kerwin, 1952$
Funderburk, King, Domino and Unna, 1953).
■
A slight effect on 5-hydroxytryptamine
responses of the isolated guinea-pig ileum was
recorded here with a high concentration (1.6 x 10 )
■
of benzimidazole, though there was no effect on
histamine-Induced contractions.
Dihydroergotamine.
On the guinea-pig ileum, the
-
antagonism between dihydroergotamine and 5-hydroxy¬
tryptamine is xtfeak and not clearly specific. When
-5
concentrations of 2.5 x 10"" — 2.5 x 10 were used,
the response to 5-hydroxytryptamine was depressed,
but the response to histamine was also depressed,
sometimes more than that to 5-hydroxytryptamine.
(Gaddum and fiameed, 1954).
Similar effects were recorded here. A single




guinea-pig ileum preparation for 5-10 minutes.
The responses to 5-hydroxytryptamine were depressed
and recovered slowly} while those to histamine were
less depressed and recovered rapidly.
Nicotine.
Rocha e Silva et al (1953) have
studied the antagonistic effect of high doses of
nicotine on the responses of the guinea-pig ileum
to nicotine, 5-hydroxytryptamine, acetylcholine,
histamine and bradykinin. They showed that
"moderate paralysing doses of nicotine", (i.e. 3 -
_6
13 x 10 nicotine base in the bathing fluid)
abolished the responses to 5-hydroxytryptamine and
depressed those to the other drugs studied. If
6
larger doses of nicotine (26 x 10 ) were given,
the muscle "escaped" from the inhibitory effect
and responded again to 5-hydroxytryptamine as well
as to the other drugs. In both these cases,
responses to the routine dose of nicotine (0,6 x
6
10" ) were completely abolished.
It was shown here that, in a concentration of
4
10 , nicotine caused a large contraction of the
isolated guinea-pig ileum with spontaneous
relaxation}/
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relaxation? after this, responses to small doses
of nicotine were blocked while responses to
5-hydroxytryptamine, acetylcholine and histamine
were all reduced, A single dose of nicotine,
5
which gave a bath-concentration of 10 caused a
block of nicotine responses and a marked reduction
of the 5-hydroxytryptaraine responses. Increased
7
single doses, from 2,5 x 10 — 10 caused a
complete block of the effect of 5-hydroxytryptamine.
The tissue was still responsive to these large
single doses of nicotine (see discussion, p. 165).
5-hydroxytryptamine.
It is possible to induce a specific
desensitisation of the guinea-pig ileum to 5-hydroxy¬
tryptaraine, by exposure of the tissue to high
concentrations of this drug. Gaddum, (1853), show-
ed that this desensitisation prevented also,
responses to tryptamine, and that, following a large
dose of tryptamine, responses to both it and
5-hydroxytryptaiaine were abolished, but not those
to substance P.
_ 6
After doses of up to 6 x 1C~ 5-hydroxy¬
tryptamine, Rocha e Silva et al (1953) showed that
responses/
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responses to this drug were blocked whereas those to
nicotine, acetylcholine, histamine and pilocarpine
were unaffected. This block developed quickly
and was easily reversible.
In the present experiments, a block of
5-hydroxytryptamine responses in the guinea-pig
ileum was obtained with a continuous concentration
6
of 10" 5-hydroxytryptamine in the bathing fluid.
Responses to nicotine, acetylcholine and histamine
were only slightly reduced. This confirms some of
the results of Roeha et al.(1953).
•r Atropine and the atropine-like compounds.
Atropine has an ant i-5-hydroxytryptamin
action on the spasm caused by this drug in the
isolated guinea-pig ileum. It was thought that the
nature of this inhibitory action might be better
understood if quantitative studies were made of the




and also between atropine and acetylcholine, and
atropine and histamine. These comparisons were
made, together with similar experiments where an
atropine-like compound was used in place of atropine.
In each case, the pAi0 at equilibrium of each drug-|
antagonist pair was found.
The atropine-like compounds were four
synthetic drugs supplied through the courtesy of
Dr. A.C. White of the Wellcome Research laboratories.
They had been shown to be similar to atropine by
various spasraolysis and mydriasis tests. Some
notes are given later of the activities of each,
(see p. 148-149) .
Atropine is known to antagonise 5-hydroxy-
tryptamine responses on the guinea-pig ileum when
it is used in larger doses than those which
antagonise acetylcholine. This has been explained
on the theory that 5-hydroxytryptamine acts on nerve
cells and that atropine antagonises its effect by
blocking the acetylcholine liberated by these cells.
An alternative theory is that atropine acts on both
acetylcholine and 5-hydroxytryptamine-receptors. If
this were so, some other drug might have a more
specific/
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specific action on acetylcholine-receptors than
atropine itself, and it was in the hope of finding
such a drug that these experiments were done.
Atropine,
In the isolated guinea-pig ileum,
concentrations of atropine which are just sufficient
to abolish responses caused by acetylcholine and
carbachol, do not abolish responses due to
5-hydroxytryptamine. But these responses to
5-hydroxytryptamine may be reduced? and they are
abolished by higher concentrations of atropine.
Responses induced by histamine are less affected.
Various workers have described these effects,
(Rapport and Koelle, 1953? Rocha e Silva et al.
1963? Gaddum and Hameed, 1964).
The effect of atropine on responses of this
tissue is thus to inhibit those due to 6-hydroxy-
tryptamine less than those due to choline esters
and more than those due to histamine, Nicotine-
induced spasra is inhibited by atropine to about




Cambridge and Holgate (1965) estimated the
effect of atropine on the responses to these three
drugs. They used the technique of superfusion,
(Gaddura, 1953) for a portion of guinea-pig ileum
which was stimulated regularly by the same
concentration of 5-hydroxytrypt.amine. As the
concentration of atropine in the superfusion fluid
9 _ 8
was increased from 10"" - 10" the response of the
ileum was progressively reduced to 50 - 70# of its
original height. Increase of atropine to 10
did not reduce this response further. Beyond a
_ 6
concentration of 10 , Increase in atropine
concentration again caused decrease in the
5-hydroxytryptamine response. The first portion of
this atropine concentration-effect curve followed
that of atropine/acetylcholine, then after the
plateau the curve lay beside that of atropine/
histamine. These authors suggested that
5-hydroxytryptamine has two types of action, one
on the nerve net and one more directly on the
muscle. The former would be more easily blocked
by atropine and the latter would only be blocked by
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186C47 3.3 diphenyl propan-3-ol
diethylainine methiodide, This is Compound 22, of
White, Green and Hudson, (1951).
Comparisons of 186C47 with atropine showed
that both had very similar activities with reference
to carbachol, pilocarpine and histamine. 186C47
was 0.7 - 1.0 times as active as atropine in tests
on the same strip of isolated rabbit ileum, stimu¬
lated by carbachol or pilocarpine. The two
compounds were almost equivactive against the
spasm of isolated guinea-pig ileum produced by
histamine. In various other tests, including one
on mydriasis and another on histamine-induced
asthma the activity of 186C47 was found to be not
less than half the activity of atropine, (White,
1953).
54C50 3-pyrrolidino-1-phenyl-1-
cyclohexyl propan-l-ol hydrochloride. Kemadrin
(Green, 1952).
54C50 was about 0.14 times as active as
atropine in the abolition of acetylcholine spasm
in isolated guinea-pig ileum. It was active also
against/
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against carbachol in the guinea-pig ileum and
against both these spasmogenic drugs on rabbit
ileum. In higher concentrations, 54C50 could
abolish contractions due to histamine and to
barium. In mydriasis and salivation tests the
activity of 54C50 was about 0.04 that of atropine
and the effect was of shorter duration. (White,
1963).
377C5Q 3-pyrrolidino-1-phenyl- 1-cyclo
hexyl propan-l-ol methiodide. Methiodide of
■I ....
Kemadrin,
The methiodide, 377C50, had a somewhat great-
er atropine-like activity than 54C50. It had
about 0.6 the potency of atropine on acetylcholine
spasm of isolated guinea-pig ileum. It was about
0.6 as active as atropine also, on a mydriasis test
in mice. (White, 1953).
182C52 1,1 diphenyl 3-piperidino
propane-1-carbonamide hydrobromide.
The atropine-like activity of 182C62 ant of
the base from which it is derived, were equal, on a
molar basis in a mouse mydriasis test. The base
itself was more fully investigated by White and he
stated/
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stated that it was about 1.5 times as active as
atropine in the antagonism of acetylcholine-induced
spasm of isolated guinea-pig ileum. It was,
however, about 0,7 times as active as atropine in
the mouse mydriasis test (White, 1953).
Other investigations on the base were made
by Schaumann (195l)| it is his compound 9980. He
stated that it was about 0.16 times as effective
as atropine in the reduction of histamine responses
of the isolated guinea-pig colon. But in a
salivation test in kittens it was twice as potent
as atropine.
Experimental method.
The organ-bath was closely
connected by a two-way tap, to one reservoir con¬
taining Tyrode solution and to another containing
Tyrode solution plus a particular concentration of
antagonist. A change to permit contact of the
tissue and the antagonist solution could thus be
made without interruption of the dosage regimen.
It was usually done during the washing out of a
drug dose.
In the estimation of the effects of atropine
and the atropine-like compounds, regular responses
of/
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of the isolated guinea-pig ileum to 5-hydroxy~
tryptamine (or acetylcholine or histamine) were
first obtained in the presence of Tyrode solution.
Then this solution was replaced by Tyrode containing
antagonist. The drug dose was increased by ten
times and given until the response was again steady,
(16 - 20 minutes). Sometimes the antagonist -
Tyrode solution was removed and the recovery of
the responses to the single dose of 5-hydroxy-
tryptamine in Tyrode solution was recorded.
The index, pAic,is different from that
of Schild (1947), only in that Schild expressed all
responses in terms of the maximum response obtained
in the absence of antagonist, whereas here responses
are measured in terms of the steady submaximal
response to the single dose of drug.(Reuse, 1947).
Also, Schild's index was always qualified by the
length of contact of the antagonist and the tissue,
but here dosage was continued until the response
reached a steady level (equilibrium response).
The/
Figure 16
Guinea-pig ileum in Tyrode at 37°C, 2 ml bath.
First tracing!
Responses to 10 ng hydroxy-
/N 7
tryptamine$ from 1, 10" 54C60 present in Tyrode
until the end of the experiment and doses of
hydroxytryptamine increased to 100 ng.
Second tracing:
Fresh portion of ileum in Tyrode,
A
Responses to 20 ng hydroxytryptamine5 from 1,
?
5 x 10" 54C50 present in Tyrode and doses of
hydroxytryptamine increased to 200 ng.
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The effect of atropine and the atropine-like
compounds on 5-hydroxytryptamine responses was
compared in a short series of experiments with
their effect on nicotine responses. Doses of
nicotine and 5-hydroxytryptamine which caused
similar steady responses (3 minute interval) were
found and then given alternately throughout the
rest of the experiment. A particular concentration
of one of the antagonists was introduced, and allow¬
ed to remain continuously during dosing until
steady responses were again obtained (8-20 minutes),
The antagonist solution was then removed and doses
were given until the recovery from inhibition
appeared to be complete.
Results of estimations on atropine and the
atropine-like compounds.
For each of the antagonists the pAio
was found for 5-hydroxytryptamine, as well as for
acetylcholine and histamine.
The equilibrium response to 10 times the
standard dose, in the presence of a given concen¬
tration of antagonist, was compared with the
response/
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response to a single dose, in the absence of
antagonist. All the estimates were made on
portions of the isolated guinea-pig ileum taken
within 10 cm of the caecum.
The results are tabled for each drug-
antagonist pair, showing the negative logarithm of
the molar concentration of the antagonist and the
equilibrium response to 10 times the dose of the
drug. The best line fit was calculated from the
results by the use of the formula for the simple
regression line.
That isi-
y = mean of y values,
y - y = b (x - x) x = mean of x values,
\^here b = S [y (x - x)]
"3
S (x - x)
Sum of the products of y and the differ-
ences of x from their mean
Sum of the squares of the differences of
x from their mean.
The point at which this line has y « 100 is
the pAio- on the graph, the point at which this
line crossed the line corresponding to 100^ is the
pAio. This is the negative logarithm of the molar
concentration of the antagonist, in the presence of




cause a response equal to that given by the single dose in
the absence of antagonist.
* «ir
For example, for 5-hydroxytryptamine and atropine, to find
best line fit -
y = y+ b(x-x) x = neg. log. molar concentration
antagonist.
y = response,








x e 6.063 y = 93.17
S(x - x) = 1.6133 S [y (x - X)] = 111.95
„ = S [y Cx - x)J _ 68_4
3
S (x - x)
y - 93.17 + 69.4x - (69.4 X 6,063)
for pAio y - - 93.17 + 69.4x - 420.77
x = 6.310 = pAio
Two points on the best line were found by substitution
of values of x and the line was placed on the graph.
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Effect of atropine.
Under the experimental conditions
which were used here, fairly high concentrations
?
( > 10" ) of atropine were necessary to cause
inhibition of the responses of the isolated guinea-
pig ileum to the 10-fold dose of 5-hydroxytryptainine.
In fact, the atropine concentration corresponding
to pAio for 5-hydroxytryptamine was more than 100
times greater than that for acetylcholine. For
histamine, the atropine concentration was more than
10 times greater than that for 6-hydroxytryptamine.
Where an attempt was made to measure the
inhibitory effect of a concentration of atropine
7
less than 10"* , on the responses to 5-hydroxy¬
tryptamine , instead of the expected > 100^ response
to the 10-fold dose there was a rapid progressive
decrease in response. In one experiment where
dosage was continued for 40 minutes after the
introduction of the antagonist, the responses
recovered somewhat and became steady at 60^. This
may indicate that the lower concentrations of
atropine take some time to reach their full effect
and that meanwhile, the uninhibited large doses of




In a single experiment, where responses to
6-hydroxytryptamine and nicotine were matched,
6
atropine (10** ) was introduced into the Tyrode.
The responses to both nicotine and 6-hydroxy¬
tryptamine were similarly reduced and recovered in
parallel on removal of the atropine.
Atropine
Acetylcholine - equilibrium
response to ten times standard dose, expressed as
percentage of standard response.
Atropine Ne&. log, molar Equilibrium





2,6 x 10"9 8.43 75
6 xlO" 9 8.13 106
5x10-9 8.13 60
5-hydroxyti'yptamine - as above./
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5-hydroxytryptamine - equilibrium
response to ten times standard dose, expressed as
percentage of standard response.
Atropine Heg. log. molar Equilibrium
coneen- concentration of response
tration. atropine.
1oH 6.83 142
2 X 10-7 6.53 129
5 X 10- 7 6.13 109
10-6 5.83 81
10-6 5,83 60
4 X 10-® 5.23 38
Histamine - equilibrium response to
ten times standard dose, expressed as percentage of
standard response.
Atropine Heg. log, molar Equilibrium
coneen- concentration of response
tration atropine. ^
4 x 10"6 5.23 130
4 x 10"S 4.23 45
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5-hydroxytryptamine - equilibrium response to 10 times









concn. of/o concn. %
2 x 10" 9 8.34 143 5 X 910" 7.81 160
_ »










































5-hydroxytryptaraine - equilibrium response to 10 times















5 x 10" 7.93 178 5 x 10" 7.90 160
io-6 7.63 143 10-6 7,60 110
3








2 x 10-8 7.33 70 2 x 10-8 7.30 82
2.5 x 10"6 7.23 117 5 x 10-6 6.90 70
a
5 x 10- 6.93 84 10-7 6.60 90
7
io- 6.63 10 10-7 6.60 42
E<»
1




Acetylcholine - equilibrium response to 10 times
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Histamine ~ equilibrium response to 10 times















5 x 10 4.04 117
6
6 x 10 4.81 62
_ 5











concn. concn. % concn. concn.
7












Results of calculations of pA10 values,
y = y + b(x-x); where y « 100, x = pAi0
Antagonist





93.17 + 69.4x - 420.77
98.4 + 90.S7X - 767.13








96.7 + 28.56X - 208.77
95.33 + 144.40x - 1131.1








115.3 + 23.16X - 149.85 5.809
117.5 + 83.62X - 586.18 6.801





97.0 + 110.92x - 798,5
















Effects of the atropine-like
compounds.
All the four atropine-like
compounds were more active in the antagonism of
acetylcholine responses than in the antagonism of
5-hydroxytryptamine responses. Their activity
against histamine was much less.
I'Jhere the effect of these atropine-like
compounds on responses to 5-hydroxy tryptamine was
compared with their effect on responses to nicotine,
these were found to be very similar. Matching
responses to nicotine and 5-hydroxytryptamine were
similarly reduced by a given concentration of one
of these compounds, and, on removal of the antagon¬
ist, the responses to both drugs recovered in
parallel.
Suppose the " dose-ratio'1 is a measure of
the Increase in the dose of agonist which is required
to produce, in the presence of the antagonist, a
response equal to that produced by a certain dose of
| -
agonist in the absence of antagonist. Then in the
7
presence of 186C47 (10" ) the dose ratio for nicotine
or 5-hydroxytryptamine was 10, while that for acetyl-
I
____ -
choline was 50 and that for histamine was 1.
The/
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The pAio's of the two quaternary compounds,
186C47 and 377C50, for 5-hydroxytryptamine are
almost the same. These values are only a little
less than the pAio's of these compounds for acetyl¬
choline. The other two antagonists, 54C50 and
182C62, both show a greater difference between the
pAio for acetylcholine and that for 5-hydroxy¬
tryptamine, - but whereas with 54C50 there is a
very wide scatter of the estimates of effect, with
182C52 the estimates lie close to the calculated
lines.
For 186C47 and 54C50 the concentration/
effect curves for histamine are shown and the pAi0's
were calculated. No antagonism was recorded for
histamine responses by 377C50 in concentrations less
4*6
, 4
than 10" molar. 182C52 (10" molar), itself,
caused spontaneous contractions of the guinea-pig
ileum and this made estimation of the pA10
impossible.
In most cases, any small spontaneous
contractions occurring while Tyrode solution was the






A. The antagonistic effect of
certain drugs on 5-hvdroxvtryDiamine responses in
the isolated guinea-pig ileum.
The striking similarity between the actions
of 5-hydroxytryptamine and nicotine has been con¬
firmed by this study of antagonistic effects.
Nicotine and 5-hydroxytryptamine are not, however,
interchangeable, for a large dose of either will
not block the normal response to the other.
Cocaine, 6-aminotetrahydrocarbazole,
atropine and the four atropine-like compounds, all
inhibited matching responses of the isolated guinea-
pig ileum to 5-hydroxytryptamine and nicotine to
the same extent. Responses to both drugs recovered
in parallel after removal of the antagonist. That
atropine had this action was shown by Robertson,
(1353) and by Boeha e Silva et al. (1353)$ and tha
cocaine acted similarly was shown also by Rocha e
Silva et al (1953).
Yohimbine was the only antagonist which
showed a slight discrimination between the two
drugs. It caused (in a concentration of 10 pg/ml)




response, and about 60$ inhibition of the nicotine
response. The recovery of the responses to
5-hydroxytryptamine was slightly slower than that
to nicotine. This experiment was done only twice
.
and the discrimination shown between 5-hydroxy¬
tryptamine and nicotine may not have been real.
Benzimidazole and dihydroergotamine were
both slightly more effective against S-hydroxy-
tryptamine than against histamine.
In the presence of 6-hydroxytryptamine
(1 pg/ml) the isolated guinea-pig ileum will not
respond to this drug nor to tryptamine (Gaddum, 1953).
It will however, respond to nicotine, as shown by
Rocha e Silva et al (1953) and confirmed here.
'
When the ileum was bathed with a solution
containing 100 pg of nicotine per ml, the response
to a small dose of nicotine was blocked while
- ■; ■ ■ .
. - • -
responses to 5-hydroxytryptamine, acetylcholine and
histamine were all slightly reduced. In other
experiments, single doses of 20 - 100 pg nicotine
per ml of Tyrode solution themselves caused responses
but small doses of 5-hydroxytryptamlne caused no
response.
These effects are similar to those described
by Rocha e Silva et al (1953), but these workers
reached/
lee
reached the high level of nicotine "block by-
repeated groups of doses of nicotine (GO to >100
jig/ml), ana the second and following doses in each
group generally gave very small responses. With
the progressive increase in the nicotine block they
showed a progressive "escape1' from inhibition of
the 6-hydroxytryptamine response. They explain
this by postulating that at the lower level of
nicotine block, when responses to other drugs are
also inhibited, nicotine itself is stimulating a
sympathetic inhibitory mechanism (Ambache, 1951}
Ambache and Edwards, 1951), and that with higher
levels of nicotine block, this inhibitory function
is also paralysed. The difference in these effect
is shown more clearly by these workers, possibly
because they used a routine dose of 5-hydroxy-
tryptamine more than 20 times larger than that
employed here.
The results of all these experiments bear
out the conception that 5-hydrcxytryptamine acts
through the nervous structures in this preparation,
both because of the similarity of effect of the
various antagonists on nicotine and 5-hydroxy-
•
s
tryptamine responses and particularly because both
responses are blocked by cocaine, It is believed
that/
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that nicotine acts on the nervous structures via the
parasympathetic ganglia, and that cocaine inhibits
conduction through post-ganglionic fibres. But
since excessive nicotine block is specific and
5-hydroxytryptamine block is specific (to trypta-
mines) the receptors for the two drugs cannot be the
same (Gaddum, 1956). From this, Rocha e Silva et
al (1953) conclude that 5-hydroxytryptamine must act
along the parasympathetic post-ganglionic fibres.
But they leave unexplained the fact that nicotine
is still active when 5-hydroxytryptamine has been
blocked by itself. This must mean that conduction
down the post-ganglionic fibres is unimpaired
though their surface is unresponsive to stimulation.
Alternatively, nicotine and 5-hydroxy¬
tryptamine might have distinct receptors on the
ganglion cells. Paton and Perry (1953) consider
that the paralysing action of large doses of nico¬
tine on the superior cervical ganglion of the cat is
caused by a depolarisation of the whole ganglion.
Should this be the case also in the parasympathetic
ganglia of the isolated guinea-pig ileum, it is
difficult to presume that 5-hydroxytryptamine could
cause,/
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cause a stimulation through such a nicotine-
depolarised ganglion. Thus, Gaddum and Hameed
(1963) suggest that 6-hydroxytryptamine and nicotine
act on similar but distinct ganglion cells.
B, Atropine and the atropine-like
compounds.
■
When the pilot experiments were
done for the measurement of the pA10 of atropine and
6-hydroxytryptamine, the responses to the 10-fold
dose in the presence of atropine were rapidly
diminished. If the response at a particular time,
(say 10 minutes) after the introduction of the
atropine was measured in each experiment there were
inconsistencies in the results. It appeared that
certain portions of guinea-pig ileum were more
sensitive to tachyphylaxis to stimulation by
6-hydroxytryptamine. Tachyphylaxis of this tissue
to this drug lias been noted elsewhere. (Gaddum,
1963? Rocha e Silva et al. 1963). If doses of
5-hydroxytryptaaine were continued there was some
recovery of the responses*, this must be because the
atropine had reached its full effect and tachy¬
phylaxis was no longer having its influence. In
later experiments with higher concentrations of
atropine/
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atropine and in all the experiments with the
atropine-like compounds} the antagonist rapidly
,
reached its full effect, and the responses to
5-hydroxytryptam±ne rapidly reached equilibrium
without tachyphylaxis.
Thus the application of Schild»s method, as
■
used by Beuse (1948) was employed here. In this,
.
the equilibrium response to the 10-fold close is
expressed as a percentage of the steady response to
the single dose in the absence of antagonist.
Equilibrium was reached in 15-20 minutes. Schild
(1947) expressed the response to the 10-fold dose
at a particular time after introduction of the
antagonist in terms of the maximum response obtained
in the absence of the antagonist,
Despite the difference in method., the effect¬
ive concentrations for atropine/acetylcholine and
atropine/histamine antagonism are of the same order

















































































The pA1Q for atropine/5-hydroxytryptamine
showed that atropine is more than 100 times more
effective against acetylcholine than it is against
5-hydroxytryptamine$ and more than 10 times more
effective against this drug than against histamine.
This order of activity was that found by Rapport
Koelle (1953).
Comparison of the graphs of the effect of the
various atropine-like compounds and that of atropine,
on the spasmogenic drugs showed the following points.
a) The graphs of the effect of
atropine on acetylcholine, 5-hydroxytryptamine
and histamine were clearly separated. The
graphs for 182C52 showed a similar clearly
defined activity,
b) The pAio values of 54C50 for
acetylcholine and 5-hydroxytryptamine were
themselves separated by one unit but there
was a wide scatter of the effects on both
drugs, which reduced the significance of this
result.
c) The pAj.o values of 1S6C47 and
377C50 for acetylcholine and 5-hydroxy-
tryptamine were less separated ( ~ 0.5 unit)
but the results of the individual estimations
were/
Figure 3.7
Abscissae Negative log. Molar Concentration Antagonist
Ordinates Equilibrium Response to 10x Standard dose
as percentage of Standard response
O Histamine • 5-Hyd roxytryptamine X Acetylcholine
pA10 Graphs - 186C47} 54C50J 377C50
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were less scattered.
d) The activity of 182C52 on acetyl¬
choline responses was very slightly greater
than that of atropine against acetylcholine,
(pA10 8.61 cf. 8.59). The corresponding
activity of the other compounds was less than
that of atropine (7.87, 6.80, 7.86 cf. 8.59).
e) 186C47, 377C50 and 182C52 were all
considerably more active against 5-hydroxy-
tryptamine responses than was atropine,
(pAio, 7.43, 7.25 and 7.28 cf. 6.31)}
54C50 was less active, (pA10 5.81 cf. C,31).
f) The activities of all the com¬
pounds, where measurement was made, were of
the same order with reference to histamine
responses. (pA10 all about 5).
From these results, it was interesting
to note that though 186C47, 377C50 and 182C52 are
not more active anti-acetylcholines than atropine
they are all more active anti-hydroxytryptamines
than atropine. This suggested that they are not
preventing 5-hydroxytryptamine spasm by antagonism
of the effect of acetylcholine, released by the
5-hydroxytryptamine stimulation. Or, if they were
doing/
Figure 18
Abscissae Negative log. Molar Concentration Antagonist
Ordinates Equilibrium Response to 10x Standard dose
as percentage of Standard response
O Histamine • 5-Hydroxytryptamine X Acetylcholine
pA10 Graphs - 182C52; Atropine
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doing so, it must be that they penetrate more readily
to the site of acetylcholine release than does
atropine. Alternatively, they have a more specific
anti-5-hydroxytryptamine effect on its receptors
(possibly on the ganglion cells. See p. 167).
The difference between the activities of
54C50 and 377C50 must be due to the quaternary
ammonium radicle in the latter, 186C47, whose
activity closely follows that of 377C50, also bears
a quaternary ammonium grouping. This radicle
cannot however, be essential for activity since it
is absent from the most active compound of the
series, 182C52. The nitrogen in this compound is
contained in a piperidine ring. This compound bears
also an amide group in the position in which the




The study of the antagonism, of the
responses of the isolated guinea-pig ileum to
5-hydroxytryptamine, by cocaine, 6-aminotetrahydro-
carbazole, atropine and the atropine-like compounds,
showed very clearly the similarity between nicotine
and 5-hydroxytryptamine stimulation. These antag¬
onists inhibited matching responses to these two
drugs to the same extent, and the responses recover¬
ed in parallel on removal of the antagonist.
However, an excessive dose of either nicotine
or 5-hydroxytryptamine did not block the normal
response to the other.
Consideration of the various results lends
support to the theory of Gaddum and Hameed (1854),
that 5-hydroxytryptamlne and nicotine both act on
ganglion cells, but each has its distinct type of
ganglion cell bearing its own receptors.
The quantitative comparison of anti-acetyl-
choline and anti-5-hydroxytryptamine activities of
atropine and the atropine-like compounds supplied
through the courtesy of Wellcome Research Labora¬
tories, showed that three of them had a more
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